{
    "data": [
        {
            "title": "A Look At Rhythm Pharmaceuticals (RYTM) Valuation After Recent Mixed Share Price Performance",
            "description": "<div class=\"sc-d08486b0-3 byoTNg\" data-cy-id=\"article-content\"><div class=\"relative grid grid-rows-[25px_auto] place-items-center bg-surface @container/article-body-ad [[data-brand='v2']_&amp;]:bg-surface-1\" data-cy-id=\"article-body-ad\"><div class=\"text-tiny text-softer\">Advertisement</div><div class=\"relative h-[250px] min-h-[250px] w-[300px] min-w-[300px] @[380px]/article-body-ad:h-[280px] @[380px]/article-body-ad:min-h-[280px] @[380px]/article-body-ad:w-[336px] @[380px]/article-body-ad:min-w-[336px]\"><div data-fuse=\"news_incontent_1\" id=\"news_incontent_1\"></div></div></div><h2>Rhythm Pharmaceuticals overview</h2> <p>Rhythm Pharmaceuticals (RYTM) has drawn investor attention after recent trading, with the stock last closing at US$99.15 and showing mixed returns over the past week, month and past 3 months.</p> <p><a class=\"company-report-links\" data-vars-link-type=\"cta_company_latest_analysis\" href=\"https://www.simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-rytm/rhythm-pharmaceuticals\" rel=\"noopener noreferrer\" target=\"_blank\">See our latest analysis for Rhythm Pharmaceuticals.</a></p> <p>The recent 1-day share price return of 0.51% to US$99.15 sits against weaker 30 and 90 day share price returns, while the very large 5 year total shareholder return points to a stock that has already rewarded patient holders. Recent moves may reflect shifting views on Rhythm Pharmaceuticals' growth potential in rare disease treatments and how investors balance that against risks and valuation.</p> <p>If Rhythm Pharmaceuticals has caught your eye, it could be a good moment to see what else is setting the pace in the sector via our list of <a class=\"company-report-links\" data-vars-link-type=\"cta_screener_healthcare_ai\" href=\"https://simplywall.st/discover/investing-ideas/434426/healthcare-ai/us\" rel=\"noopener noreferrer\" target=\"_blank\">30 healthcare AI stocks</a>.</p> <p>With Rhythm trading at US$99.15, an intrinsic value estimate at a discount, and a sizeable gap to the US$141.80 analyst target, you have to ask: is this a genuine mispricing or is future growth already fully reflected?</p> <h2>Most Popular Narrative: 24.6% Undervalued</h2> <p>Rhythm Pharmaceuticals' most followed valuation narrative pegs fair value at $131.50, comfortably above the recent $99.15 close. This raises clear questions about what is priced in around rare disease obesity.</p> <blockquote> <p><em>Rhythm Pharmaceuticals enters late February 2026 as the leader in \"rare disease obesity,\" a niche that has remained remarkably insulated from the broader GLP-1 price wars. The company‚Äôs core asset, Setmelanotide, has seen rapid uptake in patients with Bardet-Biedl syndrome (BBS) and POMC deficiency, where traditional weight-loss drugs often fail.</em></p> </blockquote> <p><a class=\"company-report-links\" data-vars-link-type=\"cta_narrative_prompt_after_quote\" href=\"https://www.simplywall.st/narratives/2s99oift-rare-obesity-leadership-can-setmelanotide-scale-beyond-the-clinic\" rel=\"noopener noreferrer\" target=\"_blank\">Read the complete narrative.</a></p> <p>It is worth examining how a single rare disease franchise supports that higher fair value. The narrative leans heavily on scaling revenue, future margins and a shift to sustained profitability, and it is important to understand which specific cash flow assumptions are most influential.</p> <p><strong>Result: Fair Value of $131.50 (UNDERVALUED)</strong></p> <p><a class=\"company-report-links\" data-vars-link-type=\"cta_user_generated_narrative\" href=\"https://www.simplywall.st/narratives/2s99oift-rare-obesity-leadership-can-setmelanotide-scale-beyond-the-clinic\" rel=\"noopener noreferrer\" target=\"_blank\">Have a read of the narrative in full and understand what's behind the forecasts.</a></p> <p>However, the story could change quickly if key Phase 3 programs disappoint, or if the current annual net loss of about US$197.7m forces fresh equity raises.</p> <p><a class=\"company-report-links\" data-vars-link-type=\"risks_narrative_cta\" href=\"https://www.simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-rytm/rhythm-pharmaceuticals\" rel=\"noopener noreferrer\" target=\"_blank\">Find out about the key risks to this Rhythm Pharmaceuticals narrative.</a></p> <h2>Another view: rich sales multiple despite DCF upside</h2> <p>Our DCF model suggests Rhythm could be trading below future cash flow value at $448.88 per share, which supports the undervalued narrative. Yet the current P/S of 38x is far higher than the 21.5x fair ratio, the 18.3x peer average and the 11.9x US biotechs average. Is that gap a cushion or a warning sign for you?</p> <p><a class=\"company-report-links\" data-vars-link-type=\"alternate_preferred_multiple_cta\" href=\"https://www.simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-rytm/rhythm-pharmaceuticals/valuation\" rel=\"noopener noreferrer\" target=\"_blank\">See what the numbers say about this price ‚Äî find out in our valuation breakdown.</a></p> <p></p><figure><a class=\"company-report-links\" data-vars-link-type=\"infographic\" href=\"https://www.simplywall.st//stocks/us/pharmaceuticals-biotech/nasdaq-rytm/rhythm-pharmaceuticals/valuation\" rel=\"noopener noreferrer\" target=\"_blank\"><img alt=\"NasdaqGM:RYTM P/S Ratio as at Feb 2026\" class=\"sc-3204b94-0 iJdSPa\" height=\"476\" loading=\"lazy\" src=\"https://images.simplywall.st/company/ba489216-1091-4391-b1fd-ceff0fab18eb/chart/ps-multiple-vs-industry?date=2026-02-26\" width=\"746\"/></a><figcaption>NasdaqGM:RYTM P/S Ratio as at Feb 2026</figcaption></figure><p> </p><h2>Next Steps</h2> <p>All this mixed sentiment only matters if it helps you make a clear call. Take a moment to review the underlying data, weigh the long term potential and see how it fits your portfolio, then round out your view by checking the <a class=\"company-report-links\" data-vars-link-type=\"cta_rewards_analysis\" href=\"https://www.simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-rytm/rhythm-pharmaceuticals\" rel=\"noopener noreferrer\" target=\"_blank\">3 key rewards</a>.</p> <h2>Looking for more investment ideas?</h2> <p>If you stop with just one stock idea, you could miss opportunities that fit your goals better. Use the screener to widen your field of potential winners.</p> <ul> <li>Spot potential bargains by scanning our list of <a class=\"company-report-links\" data-vars-link-type=\"cta_screener_undervalued\" href=\"https://simplywall.st/discover/investing-ideas/473076/high-quality-undervalued-stocks/us\" rel=\"noopener noreferrer\" target=\"_blank\">53 high quality undervalued stocks</a> that pair quality with prices the market may be overlooking.</li> <li>Prioritise resilience and sleep easier by reviewing <a class=\"company-report-links\" data-vars-link-type=\"cta_screener_low_risk\" href=\"https://simplywall.st/discover/investing-ideas/473631/low-risk-leaders/us\" rel=\"noopener noreferrer\" target=\"_blank\">80 resilient stocks with low risk scores</a> built around companies with more measured risk profiles.</li> <li>Get ahead of the crowd by checking our <a class=\"company-report-links\" data-vars-link-type=\"cta_screener_undiscovered_gems\" href=\"https://simplywall.st/discover/investing-ideas/473622/high-quality-undiscovered-gems/us\" rel=\"noopener noreferrer\" target=\"_blank\">screener containing 23 high quality undiscovered gems</a> where strong fundamentals have not yet attracted broad attention.</li> </ul> <p><em> This article by Simply Wall St is general in nature. <strong>We provide commentary based on historical data\n    and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice.</strong> It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your\n    financial situation. We aim to bring you long-term focused analysis driven by fundamental data.\n    Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material.\n    Simply Wall St has no position in any stocks mentioned.</em></p><div class=\"sc-80c0fb9d-0 hLZAWP\"><h3 class=\"m-0 text-balance text-mega font-medium mb-4 font-serif\"><strong>New: </strong>AI Stock Screener &amp; Alerts</h3><p>Our new AI Stock Screener scans the market every day to uncover opportunities.</p><p>‚Ä¢ Dividend Powerhouses (3%+ Yield)<br/>‚Ä¢ Undervalued Small Caps with Insider Buying<br/>‚Ä¢ High growth Tech and AI Companies<br/><br/>Or build your own from over 50 metrics.</p><a class=\"sc-kuACkN kjLJKA !text-[--s-button-primary-color-text] !no-underline\" data-focus=\"dashed\" href=\"https://simplywall.st/features/stock-screener\" target=\"_blank\">Explore Now for Free</a></div></div>",
            "pub_date": "2026-02-26 20:21:30",
            "link": "https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-rytm/rhythm-pharmaceuticals/news/a-look-at-rhythm-pharmaceuticals-rytm-valuation-after-recent",
            "source": "simplywall",
            "kind": 1,
            "language": "en"
        },
        {
            "title": "Is Saba‚Äôs Renewed Activism Pushing ASA (ASA) Toward a New Strategic Path for Shareholders?",
            "description": "<div class=\"sc-d08486b0-3 byoTNg\" data-cy-id=\"article-content\"><ul> <li>On February 19, 2026, activist investor Saba Capital Management LP announced it had submitted an updated presentation urging ASA Gold and Precious Metals Limited‚Äôs Board to undertake a comprehensive strategic review, including clarified potential alternatives. </li> <li>This renewed activist push highlights how governance pressure at a specialized gold-miner-focused closed-end fund can influence expectations around its future direction and structure. </li> <li>Against this backdrop, we‚Äôll examine how Saba Capital‚Äôs call for a comprehensive strategic review could influence ASA Gold and Precious Metals‚Äô investment narrative. </li> </ul><p>Uncover the next big thing with <a class=\"company-report-links\" data-vars-link-type=\"intro\" href=\"https://simplywall.st/discover/investing-ideas/472945/elite-penny-stocks/us\" rel=\"noopener noreferrer\" target=\"_blank\">30 elite penny stocks</a> that balance risk and reward.</p><div class=\"relative grid grid-rows-[25px_auto] place-items-center bg-surface @container/article-body-ad [[data-brand='v2']_&amp;]:bg-surface-1\" data-cy-id=\"article-body-ad\"><div class=\"text-tiny text-softer\">Advertisement</div><div class=\"relative h-[250px] min-h-[250px] w-[300px] min-w-[300px] @[380px]/article-body-ad:h-[280px] @[380px]/article-body-ad:min-h-[280px] @[380px]/article-body-ad:w-[336px] @[380px]/article-body-ad:min-w-[336px]\"><div data-fuse=\"news_incontent_1\" id=\"news_incontent_1\"></div></div></div><h2>What Is ASA Gold and Precious Metals' Investment Narrative?</h2><p>To own ASA Gold and Precious Metals today, you really have to believe in two things: that a concentrated, high-octane exposure to gold miners still deserves a place in a portfolio, and that the closed-end fund‚Äôs structure and governance will not work against you. The recent surge in returns and very low price to earnings multiple are attractive on the surface, but they also sit alongside large one off gains and a fund that generates limited recurring revenue. Saba Capital‚Äôs renewed push for a comprehensive strategic review adds a fresh near term catalyst around the discount to net asset value, fee structure, and even the fund‚Äôs offshore setup, but it also injects more uncertainty into an already volatile vehicle with a relatively inexperienced board. The activism could prove material, yet it may not change the core reality that ASA‚Äôs fortunes remain tightly tied to swings in gold equities.</p> However, one governance risk in particular is something investors should not ignore.\n\nASA Gold and Precious Metals' shares are on the way up, but could they be overextended? <a class=\"company-report-links\" data-vars-link-type=\"integrated-pitch\" href=\"https://simplywall.st/stocks/us/diversified-financials/nyse-asa/asa-gold-and-precious-metals/valuation\" rel=\"noopener noreferrer\" target=\"_blank\">Uncover how much higher they are than fair value</a>.<h2>Exploring Other Perspectives</h2><figure><a class=\"company-report-links\" data-vars-link-type=\"infographic\" href=\"https://simplywall.st/stocks/us/diversified-financials/nyse-asa/asa-gold-and-precious-metals\" rel=\"noopener noreferrer\" target=\"_blank\"><img alt=\"ASA 1-Year Stock Price Chart\" class=\"sc-3204b94-0 iJdSPa\" height=\"476\" loading=\"lazy\" src=\"https://images.simplywall.st/company/530981a7-5ecc-48bb-9ea8-c64c17ef3d80/chart/quote-price\" width=\"746\"/></a><figcaption>ASA 1-Year Stock Price Chart</figcaption></figure> The Simply Wall St Community currently has 1 fair value estimate around US$42.72, yet recent activism and governance turnover may matter more for ASA‚Äôs path than any single model suggests, so you should weigh multiple viewpoints.<p><a class=\"company-report-links\" data-vars-link-type=\"integrated-pitch\" href=\"https://simplywall.st/community/narratives/us/diversified-financials/nyse-asa/asa-gold-and-precious-metals\" rel=\"noopener noreferrer\" target=\"_blank\">Explore another fair value estimate on ASA Gold and Precious Metals</a> - why the stock might be worth as much as $42.72!</p><h2>The Verdict Is Yours</h2><p>Disagree with this assessment? Extraordinary investment returns rarely come from following the herd, so go with your instincts.</p><ul><li>A great starting point for your ASA Gold and Precious Metals research is our analysis highlighting <a class=\"company-report-links\" data-vars-link-type=\"conclusion\" href=\"https://simplywall.st/stocks/us/diversified-financials/nyse-asa/asa-gold-and-precious-metals\" rel=\"noopener noreferrer\" target=\"_blank\">2 key rewards and 2 important warning signs</a> that could impact your investment decision.</li><li><a class=\"company-report-links\" data-vars-link-type=\"conclusion\" href=\"https://simplywall.st/stocks/us/diversified-financials/nyse-asa/asa-gold-and-precious-metals\" rel=\"noopener noreferrer\" target=\"_blank\">Our free ASA Gold and Precious Metals research report</a> provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate ASA Gold and Precious Metals' overall financial health at a glance.</li></ul><h2>Ready To Venture Into Other Investment Styles?</h2><p>Don't miss your shot at the next 10-bagger. Our latest stock picks just dropped:</p><ul><li>The future of work is here. Discover the <a class=\"company-report-links\" data-vars-link-type=\"conclusion-grid\" href=\"https://simplywall.st/discover/investing-ideas/473746/robotics-andamp-automation-stocks/global\" rel=\"noopener noreferrer\" target=\"_blank\">32 top robotics and automation stocks</a> leading the charge in AI-driven automation and industrial transformation.</li><li>Invest in the nuclear renaissance through our list of <a class=\"company-report-links\" data-vars-link-type=\"conclusion-grid\" href=\"https://simplywall.st/discover/investing-ideas/473644/nuclear-renaissance/global\" rel=\"noopener noreferrer\" target=\"_blank\">84 elite nuclear energy infrastructure plays</a> powering the global AI revolution.</li><li>We've uncovered the <a class=\"company-report-links\" data-vars-link-type=\"conclusion-grid\" href=\"https://simplywall.st/discover/investing-ideas/473528/dividend-fortresses/us\" rel=\"noopener noreferrer\" target=\"_blank\">15 dividend fortresses</a> yielding 5%+ that don't just survive market storms, but thrive in them.</li></ul> <p><em> This article by Simply Wall St is general in nature. <strong>We provide commentary based on historical data\n    and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice.</strong> It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your\n    financial situation. We aim to bring you long-term focused analysis driven by fundamental data.\n    Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material.\n    Simply Wall St has no position in any stocks mentioned.</em></p><div class=\"sc-80c0fb9d-0 hLZAWP\"><h3 class=\"m-0 text-balance text-mega font-medium mb-4 font-serif\"><strong>New: </strong>Manage All Your Stock Portfolios in One Place</h3><p>We've created the <strong>ultimate portfolio companion</strong> for stock investors, <strong>and it's free.</strong></p><p>‚Ä¢ Connect an unlimited number of Portfolios and see your total in one currency<br/>‚Ä¢ Be alerted to new Warning Signs or Risks via email or mobile<br/>‚Ä¢ Track the Fair Value of your stocks<br/></p><a class=\"sc-kuACkN kjLJKA !text-[--s-button-primary-color-text] !no-underline\" data-focus=\"dashed\" href=\"https://simplywall.st/features/portfolio\" target=\"_blank\">Try a Demo Portfolio for Free</a></div></div>",
            "pub_date": "2026-02-26 20:21:30",
            "link": "https://simplywall.st/stocks/us/diversified-financials/nyse-asa/asa-gold-and-precious-metals/news/is-sabas-renewed-activism-pushing-asa-asa-toward-a-new-strat",
            "source": "simplywall",
            "kind": 1,
            "language": "en"
        },
        {
            "title": "McDonald's (MCD) Margin Steadiness Tested By Premium Valuation After FY 2025 Results",
            "description": "<div class=\"sc-d08486b0-3 byoTNg\" data-cy-id=\"article-content\"><p>McDonald's (MCD) closed out FY 2025 with fourth quarter revenue of US$7.0 billion and basic EPS of US$3.03, alongside net income of US$2,164 million, setting the tone for a year where trailing 12 month revenue reached US$26.9 billion and EPS came in at US$12.00. Over the past few quarters, revenue has moved from US$5,956 million in Q1 2025 to US$7,078 million in Q3 2025 before landing at US$7,009 million in Q4. Quarterly EPS ranged between US$2.61 and just over US$3.19, with a trailing net profit margin of 31.9%.</p> <a class=\"company-report-links\" data-vars-link-type=\"cta_company_latest_analysis_earnings\" href=\"https://www.simplywall.st/stocks/us/consumer-services/nyse-mcd/mcdonalds\" rel=\"noopener noreferrer\" target=\"_blank\">See our full analysis for McDonald's.</a> <p>With the headline numbers on the table, the next step is to see how this earnings profile lines up against the widely held narratives around McDonald's growth, income appeal, and long term resilience.</p> <p><a class=\"company-report-links\" data-vars-link-type=\"cta_range_narrative\" href=\"https://www.simplywall.st/narratives/8bb6ppxs-mcdonalds-a-fundamental-and-historical-valuation\" rel=\"noopener noreferrer\" target=\"_blank\">See what the community is saying about McDonald's</a></p> <figure><a class=\"company-report-links\" data-vars-link-type=\"infographic\" href=\"https://www.simplywall.st/stocks/us/consumer-services/nyse-mcd/mcdonalds/past\" rel=\"noopener noreferrer\" target=\"_blank\"><img alt=\"NYSE:MCD Earnings &amp; Revenue History as at Feb 2026\" class=\"sc-3204b94-0 iJdSPa\" height=\"476\" loading=\"lazy\" src=\"https://images.simplywall.st/company/0622fcd5-994c-414f-9711-d79f4e7abbc6/chart/earnings-and-revenue-history?date=2026-02-26\" width=\"746\"/></a><figcaption>NYSE:MCD Earnings &amp; Revenue History as at Feb 2026</figcaption></figure> <div class=\"relative grid grid-rows-[25px_auto] place-items-center bg-surface @container/article-body-ad [[data-brand='v2']_&amp;]:bg-surface-1\" data-cy-id=\"article-body-ad\"><div class=\"text-tiny text-softer\">Advertisement</div><div class=\"relative h-[250px] min-h-[250px] w-[300px] min-w-[300px] @[380px]/article-body-ad:h-[280px] @[380px]/article-body-ad:min-h-[280px] @[380px]/article-body-ad:w-[336px] @[380px]/article-body-ad:min-w-[336px]\"><div data-fuse=\"news_incontent_1\" id=\"news_incontent_1\"></div></div></div><h2>31.9% net margin supports quality story</h2> <ul> <li>Over the last 12 months, McDonald's converted US$26.9b of revenue into US$8.6b of net income, for a 31.9% net margin that sits slightly above last year's 31.7%.</li> <li>Consensus narrative expects tech investments, an asset light model, and international expansion to support strong margins. The current 31.9% margin alongside trailing EPS of US$12.00 gives some backing to that bullish view, even as:\n    <ul> <li>Same restaurant sales growth in 2025 swung from a 1% decline in Q1 to positive growth of 3.8% and 3.6% in Q2 and Q3, showing mixed traffic trends beneath the margin stability.</li> <li>Net income over the last four quarters moved in a relatively tight range between US$1.9b and US$2.3b, which fits the idea of steady earnings but not rapid acceleration.</li> </ul> </li> </ul> <p>McDonald's Future Earnings Per Share Growth</p> <h2>Store base tops 44,000 with mixed traffic</h2> <ul> <li>Total restaurants increased from 43,756 in Q1 2025 to 44,599 by Q3 2025, while same restaurant sales growth moved from a 1% decline in Q1 to gains of 3.8% in Q2 and 3.6% in Q3.</li> <li>Bears highlight the risk that declining low income traffic and market saturation could pressure U.S. revenues. The swing from a 1.5% decline in same restaurant sales in Q3 2024 to positive mid single digit growth in 2025 supports the idea that traffic is not uniformly weak, even as:\n    <ul> <li>The reliance on higher same restaurant sales growth to support future earnings means any renewed traffic softness could limit how much benefit McDonald's gets from its larger 44,000 plus store base.</li> <li>Concerns about market saturation and franchisee economics remain relevant, because unit growth from 42,819 restaurants in Q3 2024 to 44,599 in Q3 2025 needs to be matched by healthy guest counts to sustain systemwide sales.</li> </ul> </li> </ul> <p>Critics who focus on traffic risk may want to see how that concern stacks up against the numbers in the dedicated bear case for McDonald's, which digs into same restaurant sales trends, cost pressures, and unit growth assumptions. <a href=\"?utm_medium=finance_user&amp;utm_campaign=cta_bear_narrative_link&amp;utm_source=post\" rel=\"nofollow noopener noreferrer\" target=\"_blank\"><strong>üêª McDonald's Bear Case</strong></a></p> <h2>Premium valuation above DCF fair value</h2> <ul> <li>At a share price of US$333.01, McDonald's trades at a trailing P/E of 27.6x versus the US Hospitality industry average of 23.2x, sits below the peer average of 55.8x, and is above a DCF fair value estimate of about US$242.21.</li> <li>Supportive investors point to 5 year annual earnings growth of 8.3% and forecast earnings growth of roughly 6.8% per year. Those figures, combined with a 2.23% dividend yield and a 31.9% net margin, heavily support the bullish case that a premium P/E can be justified, even as:\n    <ul> <li>The gap between the current share price of US$333.01 and the DCF fair value of about US$242.21 underlines the risk that some buyers are paying above modeled cash flow value.</li> <li>Forecast revenue growth of about 5.1% per year is not especially high, so a 27.6x P/E relies on confidence that margins and earnings growth near 6.8% can be maintained.</li> </ul> </li> </ul> <p>If you're trying to decide whether that premium price tag fits with your own expectations for growth and cash generation, it can help to see how bullish investors frame the long term story around digital, margins, and capital returns in one place. <a href=\"?utm_medium=finance_user&amp;utm_campaign=cta_bull_narrative_link&amp;utm_source=post\" rel=\"nofollow noopener noreferrer\" target=\"_blank\"><strong>üêÇ McDonald's Bull Case</strong></a></p> <h2>Next Steps</h2> <p>To see how these results tie into long-term growth, risks, and valuation, check out the full range of <a class=\"company-report-links\" data-vars-link-type=\"conclusion_cta_when_narratives_exist\" href=\"https://www.simplywall.st/narratives/8bb6ppxs-mcdonalds-a-fundamental-and-historical-valuation\" rel=\"noopener noreferrer\" target=\"_blank\">community narratives</a> for McDonald's on Simply Wall St. Add the company to your <a class=\"company-report-links\" data-vars-link-type=\"conclusion_cta_when_narratives_exist\" href=\"https://simplywall.st/features/stock-watchlist\" rel=\"noopener noreferrer\" target=\"_blank\">watchlist</a> or <a class=\"company-report-links\" data-vars-link-type=\"conclusion_cta_when_narratives_exist\" href=\"https://simplywall.st/features/portfolio\" rel=\"noopener noreferrer\" target=\"_blank\">portfolio</a> so you'll be alerted when the story evolves.</p> <p>Feeling torn between the bullish and cautious takes here? You can act now by checking the full risk and reward breakdown in our <a class=\"company-report-links\" data-vars-link-type=\"cta_risks_rewards_analysis\" href=\"https://www.simplywall.st/stocks/us/consumer-services/nyse-mcd/mcdonalds\" rel=\"noopener noreferrer\" target=\"_blank\">3 key rewards and 1 important warning sign</a>.</p> <h2>See What Else Is Out There</h2> <p>McDonald's combines strong margins with a premium 27.6x P/E and a modeled fair value of about US$242.21, which may limit its appeal for value focused investors.</p> <p>If that kind of rich valuation makes you hesitate, now is a good time to check our <a class=\"company-report-links\" data-vars-link-type=\"cta_screener_undervalued\" href=\"https://simplywall.st/discover/investing-ideas/473076/high-quality-undervalued-stocks/us\" rel=\"noopener noreferrer\" target=\"_blank\">53 high quality undervalued stocks</a> and see which alternatives might align better with your price discipline.</p> <p><em> This article by Simply Wall St is general in nature. <strong>We provide commentary based on historical data\n    and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice.</strong> It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your\n    financial situation. We aim to bring you long-term focused analysis driven by fundamental data.\n    Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material.\n    Simply Wall St has no position in any stocks mentioned.</em></p><div class=\"sc-80c0fb9d-0 hLZAWP\"><h3 class=\"m-0 text-balance text-mega font-medium mb-4 font-serif\"><strong>New: </strong>Manage All Your Stock Portfolios in One Place</h3><p>We've created the <strong>ultimate portfolio companion</strong> for stock investors, <strong>and it's free.</strong></p><p>‚Ä¢ Connect an unlimited number of Portfolios and see your total in one currency<br/>‚Ä¢ Be alerted to new Warning Signs or Risks via email or mobile<br/>‚Ä¢ Track the Fair Value of your stocks<br/></p><a class=\"sc-kuACkN kjLJKA !text-[--s-button-primary-color-text] !no-underline\" data-focus=\"dashed\" href=\"https://simplywall.st/features/portfolio\" target=\"_blank\">Try a Demo Portfolio for Free</a></div></div>",
            "pub_date": "2026-02-26 20:21:30",
            "link": "https://simplywall.st/stocks/us/consumer-services/nyse-mcd/mcdonalds/news/mcdonalds-mcd-margin-steadiness-tested-by-premium-valuation",
            "source": "simplywall",
            "kind": 1,
            "language": "en"
        },
        {
            "title": "OneMain Holdings Gains Institutional Attention With Valuation Gap In Russell 1000",
            "description": "<div class=\"sc-d08486b0-3 byoTNg\" data-cy-id=\"article-content\"><ul> <li>OneMain Holdings, Inc. (NYSE:OMF) is drawing increased attention for its role in consumer finance, and its presence in the Russell 1000 index reflects growing institutional interest.</li> <li>The company‚Äôs focus on personalized lending services is standing out against peers and reinforcing its position in the consumer finance segment.</li> <li>Recent stock data shows NYSE:OMF closed at $56.37, with a 1 year return of 14.6% and a 3 year return of 67.9%.</li> </ul> <p>For investors watching consumer lenders, OneMain Holdings sits at an interesting crossroads. The stock trades at $56.37 and has delivered a 14.6% return over the past year and a 67.9% return over the past 3 years, which helps frame how the market has been treating the stock so far. Its inclusion in the Russell 1000 index and the associated institutional presence add another layer of attention around the name.</p> <p>What is especially relevant now is how OneMain‚Äôs personalized lending approach is helping it stand out within consumer finance. As institutional holders stay engaged and the company continues to serve a broad base of borrowers, investors may focus on how that model compares with other listed lenders. This article looks at what that growing interest might mean for those tracking NYSE:OMF today.</p> <p>Stay updated on the most important news stories for <a class=\"company-report-links\" data-vars-link-type=\"news_stay_updated_cta\" href=\"https://www.simplywall.st/stocks/us/diversified-financials/nyse-omf/onemain-holdings/valuation\" rel=\"noopener noreferrer\" target=\"_blank\">OneMain Holdings</a> by adding it to your <a class=\"company-report-links\" data-vars-link-type=\"news_stay_updated_cta\" href=\"https://simplywall.st/features/stock-watchlist\" rel=\"noopener noreferrer\" target=\"_blank\">watchlist</a> or <a class=\"company-report-links\" data-vars-link-type=\"news_stay_updated_cta\" href=\"https://simplywall.st/features/portfolio\" rel=\"noopener noreferrer\" target=\"_blank\">portfolio</a>. Alternatively, explore our <a class=\"company-report-links\" data-vars-link-type=\"news_stay_updated_cta\" href=\"https://simplywall.st/stock/NYSE/OMF\" rel=\"noopener noreferrer\" target=\"_blank\">Community</a> to discover new perspectives on OneMain Holdings.</p> <figure><a class=\"company-report-links\" data-vars-link-type=\"infographic\" href=\"https://www.simplywall.st//stocks/us/diversified-financials/nyse-omf/onemain-holdings\" rel=\"noopener noreferrer\" target=\"_blank\"><img alt=\"NYSE:OMF 1-Year Stock Price Chart\" class=\"sc-3204b94-0 iJdSPa\" height=\"476\" loading=\"lazy\" src=\"https://images.simplywall.st/company/96c4fb59-50b0-491c-875d-0eb17d0a6655/chart/quote-price?date=2026-02-26\" width=\"746\"/></a><figcaption>NYSE:OMF 1-Year Stock Price Chart</figcaption></figure> <p><a class=\"company-report-links\" data-vars-link-type=\"cta_news_ownership\" href=\"https://www.simplywall.st/stocks/us/diversified-financials/nyse-omf/onemain-holdings/ownership\" rel=\"noopener noreferrer\" target=\"_blank\">See which insiders are buying and buying and selling OneMain Holdings following this latest news.</a></p> <div class=\"relative grid grid-rows-[25px_auto] place-items-center bg-surface @container/article-body-ad [[data-brand='v2']_&amp;]:bg-surface-1\" data-cy-id=\"article-body-ad\"><div class=\"text-tiny text-softer\">Advertisement</div><div class=\"relative h-[250px] min-h-[250px] w-[300px] min-w-[300px] @[380px]/article-body-ad:h-[280px] @[380px]/article-body-ad:min-h-[280px] @[380px]/article-body-ad:w-[336px] @[380px]/article-body-ad:min-w-[336px]\"><div data-fuse=\"news_incontent_1\" id=\"news_incontent_1\"></div></div></div><h3>Quick Assessment</h3> <ul> <li><strong>‚úÖ Price vs Analyst Target</strong>: At US$56.37, OneMain trades about 22% below the US$72.71 analyst price target range midpoint.</li> <li><strong>‚úÖ Simply Wall St Valuation</strong>: The stock is described as trading 46.9% below an estimated fair value, which signals a large valuation gap.</li> <li><strong>‚ùå Recent Momentum</strong>: The 30 day return of a 14% decline shows short term weakness despite the longer term interest in the name.</li> </ul> <p>To decide whether to buy, sell or hold OneMain Holdings, you can review the latest analysis. Head to Simply Wall St's\n<a class=\"company-report-links\" href=\"https://www.simplywall.st/stocks/us/diversified-financials/nyse-omf/onemain-holdings/valuation\" rel=\"noopener noreferrer\" target=\"_blank\">company report for the latest assessment of OneMain Holdings's fair value</a>.</p> <h3>Key Considerations</h3> <ul> <li>üìä Index membership in the Russell 1000 and institutional backing indicate that OneMain is on the radar of large investors.</li> <li>üìä It may be useful to watch how the share price moves relative to the US$72.71 analyst target and to monitor whether earnings and revenue support the current single digit P/E of 8.43.</li> <li>‚ö†Ô∏è Key risks flagged include debt that is not well covered by operating cash flow and an unstable dividend track record, which are important in a consumer finance business.</li> </ul> <h3>Dig Deeper</h3> <p>For the full picture including more risks and potential rewards, check out the\n<a class=\"company-report-links\" href=\"https://www.simplywall.st/stocks/us/diversified-financials/nyse-omf/onemain-holdings\" rel=\"noopener noreferrer\" target=\"_blank\">complete OneMain Holdings analysis</a>. You can also visit the\n<a class=\"company-report-links\" href=\"https://www.simplywall.st/stock/NYSE/OMF\" rel=\"noopener noreferrer\" target=\"_blank\">community page for OneMain Holdings</a> to see how other investors think this latest news fits into the company's overall narrative.</p> <p><em> This article by Simply Wall St is general in nature. <strong>We provide commentary based on historical data\n    and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice.</strong> It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your\n    financial situation. We aim to bring you long-term focused analysis driven by fundamental data.\n    Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material.\n    Simply Wall St has no position in any stocks mentioned.</em></p><div class=\"sc-80c0fb9d-0 hLZAWP\"><h3 class=\"m-0 text-balance text-mega font-medium mb-4 font-serif\"><strong>New: </strong>AI Stock Screener &amp; Alerts</h3><p>Our new AI Stock Screener scans the market every day to uncover opportunities.</p><p>‚Ä¢ Dividend Powerhouses (3%+ Yield)<br/>‚Ä¢ Undervalued Small Caps with Insider Buying<br/>‚Ä¢ High growth Tech and AI Companies<br/><br/>Or build your own from over 50 metrics.</p><a class=\"sc-kuACkN kjLJKA !text-[--s-button-primary-color-text] !no-underline\" data-focus=\"dashed\" href=\"https://simplywall.st/features/stock-screener\" target=\"_blank\">Explore Now for Free</a></div></div>",
            "pub_date": "2026-02-26 20:21:30",
            "link": "https://simplywall.st/stocks/us/diversified-financials/nyse-omf/onemain-holdings/news/onemain-holdings-gains-institutional-attention-with-valuatio",
            "source": "simplywall",
            "kind": 1,
            "language": "en"
        },
        {
            "title": "Hafnia (OB:HAFNI) Valuation Check After Strong Results Dividend Payout And TORM Stake Purchase",
            "description": "<div class=\"sc-d08486b0-3 byoTNg\" data-cy-id=\"article-content\"><p>Hafnia (OB:HAFNI) has drawn investor attention after reporting its fourth quarter and full year 2025 results, announcing an 80% payout ratio dividend, and completing the purchase of 13.97% of TORM shares.</p> <p><a class=\"company-report-links\" data-vars-link-type=\"cta_company_latest_analysis\" href=\"https://www.simplywall.st/stocks/no/energy/ob-hafni/hafnia-shares\" rel=\"noopener noreferrer\" target=\"_blank\">See our latest analysis for Hafnia.</a></p> <p>The latest announcements have arrived against a backdrop of firm momentum, with a 30 day share price return of 22.03%, year to date share price return of 31.60%, and a very large 5 year total shareholder return of around 7x. This indicates investors have been responding positively to both recent earnings news and earlier corporate moves.</p> <p>If Hafnia‚Äôs recent update has you looking at shipping and energy exposure more closely, it can be a good moment to broaden your search with <a class=\"company-report-links\" data-vars-link-type=\"cta_screener_founder_led\" href=\"https://simplywall.st/discover/investing-ideas/473625/top-founder-led-companies/global\" rel=\"noopener noreferrer\" target=\"_blank\">98 top founder-led companies</a>.</p> <p>With Hafnia trading at NOK 69.14 against an analyst price target of NOK 74.25 and an intrinsic value estimate that appears materially higher, the big question is whether this signals an opportunity or if the market is already pricing in future growth.</p> <div class=\"relative grid grid-rows-[25px_auto] place-items-center bg-surface @container/article-body-ad [[data-brand='v2']_&amp;]:bg-surface-1\" data-cy-id=\"article-body-ad\"><div class=\"text-tiny text-softer\">Advertisement</div><div class=\"relative h-[250px] min-h-[250px] w-[300px] min-w-[300px] @[380px]/article-body-ad:h-[280px] @[380px]/article-body-ad:min-h-[280px] @[380px]/article-body-ad:w-[336px] @[380px]/article-body-ad:min-w-[336px]\"><div data-fuse=\"news_incontent_1\" id=\"news_incontent_1\"></div></div></div><h2>Most Popular Narrative: 5.7% Undervalued</h2> <p>Hafnia‚Äôs most followed narrative puts fair value at NOK 73.33 versus the NOK 69.14 last close. This frames the recent rally against a slightly higher anchor.</p> <blockquote> <p><em>Continuous investment in fleet renewal, including new dual-fuel and eco-efficient vessels, as well as digitalization and operational optimizations, is expected to deliver structurally lower operating costs and improved vessel earnings, supporting higher margins and long-term profitability.</em></p> </blockquote> <p><em><a class=\"company-report-links\" data-vars-link-type=\"cta_narrative_prompt_after_quote\" href=\"https://www.simplywall.st/narratives/c4usfqto-fleet-renewal-will-lower-costs-while-imo-rules-bring-uncertainty-ebkv\" rel=\"noopener noreferrer\" target=\"_blank\">Read the complete narrative.</a></em></p> <p>Curious how a shrinking revenue base, changing margins and a higher future earnings multiple still add up to that fair value tag? The full narrative sets it all out.</p> <p><strong>Result: Fair Value of NOK 73.33 (UNDERVALUED)</strong></p> <p><a class=\"company-report-links\" data-vars-link-type=\"cta_ai_narrative\" href=\"https://www.simplywall.st/narratives/c4usfqto-fleet-renewal-will-lower-costs-while-imo-rules-bring-uncertainty-ebkv\" rel=\"noopener noreferrer\" target=\"_blank\">Have a read of the narrative in full and understand what's behind the forecasts.</a></p> <p>However, there are still some clear watchpoints, including tighter emissions rules that could lift costs and an eventual structural decline in oil product demand.</p> <p><a class=\"company-report-links\" data-vars-link-type=\"risks_narrative_cta\" href=\"https://www.simplywall.st/stocks/no/energy/ob-hafni/hafnia-shares\" rel=\"noopener noreferrer\" target=\"_blank\">Find out about the key risks to this Hafnia narrative.</a></p> <h2>Another View: Earnings Multiple Sends A Mixed Signal</h2> <p>Hafnia screens as good value against peers, with a P/E of 11.6x compared with 14.7x for similar companies and 15.4x for the wider European Oil and Gas group. Yet its fair ratio is 8.8x, which implies less upside room if earnings or sentiment cool off.</p> <p>That gap between today‚Äôs 11.6x and a fair ratio of 8.8x could narrow either through price or earnings, so it is worth asking which side of that trade you feel more comfortable owning.</p> <p><a class=\"company-report-links\" data-vars-link-type=\"alternate_preferred_multiple_cta\" href=\"https://www.simplywall.st/stocks/no/energy/ob-hafni/hafnia-shares/valuation\" rel=\"noopener noreferrer\" target=\"_blank\">See what the numbers say about this price ‚Äî find out in our valuation breakdown.</a></p> <p></p><figure><a class=\"company-report-links\" data-vars-link-type=\"infographic\" href=\"https://www.simplywall.st//stocks/no/energy/ob-hafni/hafnia-shares/valuation\" rel=\"noopener noreferrer\" target=\"_blank\"><img alt=\"OB:HAFNI P/E Ratio as at Feb 2026\" class=\"sc-3204b94-0 iJdSPa\" height=\"476\" loading=\"lazy\" src=\"https://images.simplywall.st/company/32d1ec97-afa0-4381-bbb7-1597a7549fe3/chart/pe-multiple-vs-industry?date=2026-02-26\" width=\"746\"/></a><figcaption>OB:HAFNI P/E Ratio as at Feb 2026</figcaption></figure><p> </p><h2>Next Steps</h2> <p>If this mix of positives and concerns feels balanced to you, you may want to review the full picture for yourself, including <a class=\"company-report-links\" data-vars-link-type=\"cta_risks_rewards_analysis\" href=\"https://www.simplywall.st/stocks/no/energy/ob-hafni/hafnia-shares\" rel=\"noopener noreferrer\" target=\"_blank\">1 key reward and 2 important warning signs</a>.</p> <h2>Looking for more investment ideas?</h2> <p>If Hafnia has sharpened your focus, do not stop here. Widening your watchlist with fresh ideas can help you spot opportunities before they feel obvious.</p> <ul> <li>Zero in on quality at a discount by checking companies our screener surfaces as <a class=\"company-report-links\" data-vars-link-type=\"cta_screener_undervalued\" href=\"https://simplywall.st/discover/investing-ideas/473076/high-quality-undervalued-stocks/global\" rel=\"noopener noreferrer\" target=\"_blank\">228 high quality undervalued stocks</a> that may warrant a closer look on your radar.</li> <li>Strengthen your income stream by reviewing businesses in our list of <a class=\"company-report-links\" data-vars-link-type=\"cta_screener_dividend\" href=\"https://simplywall.st/discover/investing-ideas/473528/dividend-fortresses/global\" rel=\"noopener noreferrer\" target=\"_blank\">444 dividend fortresses</a> that could complement or contrast your existing dividend holdings.</li> <li>Reduce sleepless nights by scanning companies highlighted in our <a class=\"company-report-links\" data-vars-link-type=\"cta_screener_low_risk\" href=\"https://simplywall.st/discover/investing-ideas/473631/low-risk-leaders/global\" rel=\"noopener noreferrer\" target=\"_blank\">327 resilient stocks with low risk scores</a> and see which ones fit the role of steadier anchors in your portfolio.</li> </ul> <p><em> This article by Simply Wall St is general in nature. <strong>We provide commentary based on historical data\n    and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice.</strong> It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your\n    financial situation. We aim to bring you long-term focused analysis driven by fundamental data.\n    Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material.\n    Simply Wall St has no position in any stocks mentioned.</em></p><div class=\"sc-80c0fb9d-0 hLZAWP\"><h3 class=\"m-0 text-balance text-mega font-medium mb-4 font-serif\">Valuation is complex, but we're here to simplify it.</h3><p>Discover if Hafnia might be undervalued or overvalued with our detailed analysis, featuring <strong>fair value estimates, potential risks, dividends, insider trades, and its financial condition.</strong></p><a class=\"sc-kuACkN kjLJKA !text-[--s-button-primary-color-text] !no-underline\" data-focus=\"dashed\" href=\"/stocks/no/energy/ob-hafni/hafnia-shares/valuation\" target=\"_blank\">Access Free Analysis</a></div></div>",
            "pub_date": "2026-02-26 20:21:30",
            "link": "https://simplywall.st/stocks/no/energy/ob-hafni/hafnia-shares/news/hafnia-obhafni-valuation-check-after-strong-results-dividend",
            "source": "simplywall",
            "kind": 1,
            "language": "en"
        },
        {
            "title": "Aker BP (OB:AKRBP) Valuation Check After Strong 1 Year Returns And New North Sea Discovery",
            "description": "<div class=\"sc-d08486b0-3 byoTNg\" data-cy-id=\"article-content\"><div class=\"relative grid grid-rows-[25px_auto] place-items-center bg-surface @container/article-body-ad [[data-brand='v2']_&amp;]:bg-surface-1\" data-cy-id=\"article-body-ad\"><div class=\"text-tiny text-softer\">Advertisement</div><div class=\"relative h-[250px] min-h-[250px] w-[300px] min-w-[300px] @[380px]/article-body-ad:h-[280px] @[380px]/article-body-ad:min-h-[280px] @[380px]/article-body-ad:w-[336px] @[380px]/article-body-ad:min-w-[336px]\"><div data-fuse=\"news_incontent_1\" id=\"news_incontent_1\"></div></div></div><h2>Aker BP share performance puts recent returns in focus</h2> <p>Aker BP (OB:AKRBP) has attracted fresh attention after a run of positive returns, with the stock showing gains over the past week, month, past 3 months, year to date, and past year.</p> <p><a class=\"company-report-links\" data-vars-link-type=\"cta_company_latest_analysis\" href=\"https://www.simplywall.st/stocks/no/energy/ob-akrbp/aker-bp-shares\" rel=\"noopener noreferrer\" target=\"_blank\">See our latest analysis for Aker BP.</a></p> <p>At a share price of NOK283.6, Aker BP‚Äôs recent 90 day share price return of 15.94% and 1 year total shareholder return of 35.66% point to momentum that has built steadily rather than in a single spike, hinting at shifting expectations around its earnings outlook and risk profile.</p> <p>If strong recent gains in Aker BP have you thinking about other energy related ideas, it could be worth scanning our list of <a class=\"company-report-links\" data-vars-link-type=\"cta_screener_nuclear_renaissance\" href=\"https://simplywall.st/discover/investing-ideas/473644/nuclear-renaissance/global\" rel=\"noopener noreferrer\" target=\"_blank\">84 nuclear energy infrastructure stocks</a> as a different way to play the broader energy theme.</p> <p>With Aker BP trading at NOK283.6, sitting on a 1 year total return of 35.66% and an intrinsic discount figure of 76.8%, you have to ask: is this a genuine value opportunity or is the market already pricing in future growth?</p> <h2>Most Popular Narrative: 8% Overvalued</h2> <p>With Aker BP last closing at NOK283.6 against a narrative fair value of roughly NOK264, the current price sits a little above that widely followed estimate, which is built on detailed views of future production, margins and cash flows under a 6.5% discount rate.</p> <blockquote> <p><em>The company continues its exploration success with the Omega Alfa discovery in the Norwegian North Sea, estimated at 96 to 134 mmboe and described as one of Norway's most commercial finds in a decade, supporting Aker BP's ambition to produce more than one billion barrels from the Yggdrasil area (Key Developments).</em></p> </blockquote> <p><em><a class=\"company-report-links\" data-vars-link-type=\"cta_narrative_prompt_after_quote\" href=\"https://www.simplywall.st/narratives/ky5eq8f7-production-will-remain-resilient-as-margins-face-pressure-from-sector-shifts\" rel=\"noopener noreferrer\" target=\"_blank\">Read the complete narrative.</a></em></p> <p>Want to see what turns those discoveries into a higher fair value? The narrative leans on measured revenue growth, fatter margins and a future earnings multiple that might surprise you.</p> <p><strong>Result: Fair Value of NOK264 (OVERVALUED)</strong></p> <p><a class=\"company-report-links\" data-vars-link-type=\"cta_ai_narrative\" href=\"https://www.simplywall.st/narratives/ky5eq8f7-production-will-remain-resilient-as-margins-face-pressure-from-sector-shifts\" rel=\"noopener noreferrer\" target=\"_blank\">Have a read of the narrative in full and understand what's behind the forecasts.</a></p> <p>However, higher emissions costs and heavy reliance on a few key assets could quickly change the earnings outlook that supports that fair value story.</p> <p><a class=\"company-report-links\" data-vars-link-type=\"risks_narrative_cta\" href=\"https://www.simplywall.st/stocks/no/energy/ob-akrbp/aker-bp-shares\" rel=\"noopener noreferrer\" target=\"_blank\">Find out about the key risks to this Aker BP narrative.</a></p> <h2>Another valuation angle: P/E sends a very different signal</h2> <p>While the narrative fair value of around NOK264 suggests Aker BP is only modestly overvalued, the current P/E of 141.7x versus peers at 13.2x and a fair ratio of 15.3x points to a very rich earnings multiple. That kind of gap can mean either elevated risk or unusual confidence. Which side do you think it sits on?</p> <p><a class=\"company-report-links\" data-vars-link-type=\"alternate_preferred_multiple_cta\" href=\"https://www.simplywall.st/stocks/no/energy/ob-akrbp/aker-bp-shares/valuation\" rel=\"noopener noreferrer\" target=\"_blank\">See what the numbers say about this price ‚Äî find out in our valuation breakdown.</a></p> <p></p><figure><a class=\"company-report-links\" data-vars-link-type=\"infographic\" href=\"https://www.simplywall.st//stocks/no/energy/ob-akrbp/aker-bp-shares/valuation\" rel=\"noopener noreferrer\" target=\"_blank\"><img alt=\"OB:AKRBP P/E Ratio as at Feb 2026\" class=\"sc-3204b94-0 iJdSPa\" height=\"476\" loading=\"lazy\" src=\"https://images.simplywall.st/company/d0af4b10-b641-4834-8d79-6d4d6b3b1035/chart/pe-multiple-vs-industry?date=2026-02-26\" width=\"746\"/></a><figcaption>OB:AKRBP P/E Ratio as at Feb 2026</figcaption></figure><p> </p><p>Simply Wall St performs a discounted cash flow (DCF) on every stock in the world every day (<a class=\"company-report-links\" data-vars-link-type=\"dcf_cta\" href=\"https://www.simplywall.st/stocks/no/energy/ob-akrbp/aker-bp-shares\" rel=\"noopener noreferrer\" target=\"_blank\">check out Aker BP for example</a>). We show the entire calculation in full. You can track the result in your <a class=\"company-report-links\" data-vars-link-type=\"dcf_cta\" href=\"https://simplywall.st/features/stock-watchlist\" rel=\"noopener noreferrer\" target=\"_blank\">watchlist</a> or <a class=\"company-report-links\" data-vars-link-type=\"dcf_cta\" href=\"https://simplywall.st/features/portfolio\" rel=\"noopener noreferrer\" target=\"_blank\">portfolio</a> and be alerted when this changes, or use our stock screener to discover <a class=\"company-report-links\" data-vars-link-type=\"dcf_cta\" href=\"https://simplywall.st/discover/investing-ideas/473076/high-quality-undervalued-stocks/global\" rel=\"noopener noreferrer\" target=\"_blank\">228 high quality undervalued stocks</a>. If you <a class=\"company-report-links\" data-vars-link-type=\"dcf_cta\" href=\"https://simplywall.st/features/stock-screener\" rel=\"noopener noreferrer\" target=\"_blank\">save a screener</a> we even alert you when new companies match - so you never miss a potential opportunity.</p> <h2>Next Steps</h2> <p>If this mix of positives and concerns feels finely balanced, it is worth checking the full picture for yourself by starting with <a class=\"company-report-links\" data-vars-link-type=\"cta_risks_rewards_analysis\" href=\"https://www.simplywall.st/stocks/no/energy/ob-akrbp/aker-bp-shares\" rel=\"noopener noreferrer\" target=\"_blank\">2 key rewards and 4 important warning signs</a>.</p> <h2>Looking for more investment ideas?</h2> <p>If Aker BP has caught your attention, do not stop here. The screener can help you quickly spot other opportunities that match your style and risk comfort.</p> <ul> <li>Focus on quality first by scanning <a class=\"company-report-links\" data-vars-link-type=\"cta_screener_solid_balance_sheet\" href=\"https://simplywall.st/discover/investing-ideas/10146/solid-balance-sheet-and-fundamentals/global\" rel=\"noopener noreferrer\" target=\"_blank\">solid balance sheet and fundamentals stocks screener (369 results)</a> that pair financial strength with fundamentals many investors overlook.</li> <li>Hunt for potential mispricings with our list of <a class=\"company-report-links\" data-vars-link-type=\"cta_screener_undervalued\" href=\"https://simplywall.st/discover/investing-ideas/473076/high-quality-undervalued-stocks/global\" rel=\"noopener noreferrer\" target=\"_blank\">228 high quality undervalued stocks</a>, built to surface companies where price and fundamentals may be out of sync.</li> <li>Prioritise resilience by checking <a class=\"company-report-links\" data-vars-link-type=\"cta_screener_low_risk\" href=\"https://simplywall.st/discover/investing-ideas/473631/low-risk-leaders/global\" rel=\"noopener noreferrer\" target=\"_blank\">327 resilient stocks with low risk scores</a>, highlighting businesses with lower risk scores that might suit a steadier approach.</li> </ul> <p><em> This article by Simply Wall St is general in nature. <strong>We provide commentary based on historical data\n    and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice.</strong> It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your\n    financial situation. We aim to bring you long-term focused analysis driven by fundamental data.\n    Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material.\n    Simply Wall St has no position in any stocks mentioned.</em></p><div class=\"sc-80c0fb9d-0 hLZAWP\"><h3 class=\"m-0 text-balance text-mega font-medium mb-4 font-serif\"><strong>New: </strong>Manage All Your Stock Portfolios in One Place</h3><p>We've created the <strong>ultimate portfolio companion</strong> for stock investors, <strong>and it's free.</strong></p><p>‚Ä¢ Connect an unlimited number of Portfolios and see your total in one currency<br/>‚Ä¢ Be alerted to new Warning Signs or Risks via email or mobile<br/>‚Ä¢ Track the Fair Value of your stocks<br/></p><a class=\"sc-kuACkN kjLJKA !text-[--s-button-primary-color-text] !no-underline\" data-focus=\"dashed\" href=\"https://simplywall.st/features/portfolio\" target=\"_blank\">Try a Demo Portfolio for Free</a></div></div>",
            "pub_date": "2026-02-26 20:15:51",
            "link": "https://simplywall.st/stocks/no/energy/ob-akrbp/aker-bp-shares/news/aker-bp-obakrbp-valuation-check-after-strong-1-year-returns",
            "source": "simplywall",
            "kind": 1,
            "language": "en"
        },
        {
            "title": "Assessing Ferguson Enterprises (FERG) Valuation After A Year Of Strong Shareholder Returns",
            "description": "<div class=\"sc-d08486b0-3 byoTNg\" data-cy-id=\"article-content\"><div class=\"relative grid grid-rows-[25px_auto] place-items-center bg-surface @container/article-body-ad [[data-brand='v2']_&amp;]:bg-surface-1\" data-cy-id=\"article-body-ad\"><div class=\"text-tiny text-softer\">Advertisement</div><div class=\"relative h-[250px] min-h-[250px] w-[300px] min-w-[300px] @[380px]/article-body-ad:h-[280px] @[380px]/article-body-ad:min-h-[280px] @[380px]/article-body-ad:w-[336px] @[380px]/article-body-ad:min-w-[336px]\"><div data-fuse=\"news_incontent_1\" id=\"news_incontent_1\"></div></div></div><h2>Event context and recent performance snapshot</h2> <p>Ferguson Enterprises (FERG) has drawn investor attention after recent trading, with the share price closing at US$260.66 and month and past 3 months returns sitting in the low single digits.</p> <p><a class=\"company-report-links\" data-vars-link-type=\"cta_company_latest_analysis\" href=\"https://www.simplywall.st/stocks/us/capital-goods/nyse-ferg/ferguson-enterprises\" rel=\"noopener noreferrer\" target=\"_blank\">See our latest analysis for Ferguson Enterprises.</a></p> <p>While the recent 1-day share price return of 0.45% and 7-day share price return of 0.25% look quiet, Ferguson Enterprises has seen stronger momentum over longer horizons, with a 15.84% year to date share price return and a 50.59% 1-year total shareholder return.</p> <p>If this steady performance has you thinking about where else capital goods exposure might come from, it could be worth scanning our list of <a class=\"company-report-links\" data-vars-link-type=\"cta_screener_power_grid\" href=\"https://simplywall.st/discover/investing-ideas/473750/power-grid-technology-stocks/global\" rel=\"noopener noreferrer\" target=\"_blank\">24 power grid technology and infrastructure stocks</a> for another angle on infrastructure focused names.</p> <p>With a 1 year total return above 50% and the stock sitting only about 5% below the average analyst price target, the real question is whether Ferguson is still mispriced or whether the market already anticipates its future growth.</p> <h2>Most Popular Narrative: 30% Undervalued</h2> <p>Ferguson Enterprises' widely followed valuation framework pegs fair value at about $261, which sits just above the last close at $260.66 and frames the upside case.</p> <blockquote> <p><em>Positive growth prospects in the Waterworks segment due to robust activity in public works and infrastructure projects are expected to boost revenue. Ferguson‚Äôs involvement in large capital projects positions it well for continued growth in this diversified segment, which should help improve margins as the business scales.</em></p> </blockquote> <p><a class=\"company-report-links\" data-vars-link-type=\"cta_narrative_prompt_after_quote\" href=\"https://www.simplywall.st/narratives/bw4fdt4y-organic-share-gains-and-non-residential-strength-will-support-upside-momentum\" rel=\"noopener noreferrer\" target=\"_blank\">Read the complete narrative.</a></p> <p>Curious how a distributor earns a premium valuation tag? This narrative leans heavily on compounding revenue, thicker margins, and a future earnings multiple that assumes real staying power. The numbers behind that view are worth a closer look.</p> <p><strong>Result: Fair Value of $261 (UNDERVALUED)</strong></p> <p><a class=\"company-report-links\" data-vars-link-type=\"cta_ai_narrative\" href=\"https://www.simplywall.st/narratives/bw4fdt4y-organic-share-gains-and-non-residential-strength-will-support-upside-momentum\" rel=\"noopener noreferrer\" target=\"_blank\">Have a read of the narrative in full and understand what's behind the forecasts.</a></p> <p>However, this hinges on housing demand and pricing holding up, since weaker residential volumes or prolonged commodity deflation could quickly pressure margins and challenge that premium valuation story.</p> <p><a class=\"company-report-links\" data-vars-link-type=\"risks_narrative_cta\" href=\"https://www.simplywall.st/stocks/us/capital-goods/nyse-ferg/ferguson-enterprises\" rel=\"noopener noreferrer\" target=\"_blank\">Find out about the key risks to this Ferguson Enterprises narrative.</a></p> <h2>Another angle on valuation: cash flows say something different</h2> <p>The fair value of $261 based on earnings and growth assumptions presents Ferguson as about fairly priced, but our DCF model offers a different perspective. Using that approach, future cash flows line up closer to $219 per share, which makes the current $260.66 price appear expensive. Which lens seems more realistic to you?</p> <p><a class=\"company-report-links\" data-vars-link-type=\"alternate_dcf_cta\" href=\"https://www.simplywall.st/stocks/us/capital-goods/nyse-ferg/ferguson-enterprises/valuation\" rel=\"noopener noreferrer\" target=\"_blank\">Look into how the SWS DCF model arrives at its fair value.</a></p> <p></p><figure><a class=\"company-report-links\" data-vars-link-type=\"infographic\" href=\"https://www.simplywall.st//stocks/us/capital-goods/nyse-ferg/ferguson-enterprises/valuation\" rel=\"noopener noreferrer\" target=\"_blank\"><img alt=\"FERG Discounted Cash Flow as at Feb 2026\" class=\"sc-3204b94-0 iJdSPa\" height=\"476\" loading=\"lazy\" src=\"https://images.simplywall.st/company/787036cd-d69e-47f1-9626-806bb2088675/chart/dcf?date=2026-02-26\" width=\"746\"/></a><figcaption>FERG Discounted Cash Flow as at Feb 2026</figcaption></figure><p> </p><p>Simply Wall St performs a discounted cash flow (DCF) on every stock in the world every day (<a class=\"company-report-links\" data-vars-link-type=\"dcf_cta\" href=\"https://www.simplywall.st/stocks/us/capital-goods/nyse-ferg/ferguson-enterprises\" rel=\"noopener noreferrer\" target=\"_blank\">check out Ferguson Enterprises for example</a>). We show the entire calculation in full. You can track the result in your <a class=\"company-report-links\" data-vars-link-type=\"dcf_cta\" href=\"https://simplywall.st/features/stock-watchlist\" rel=\"noopener noreferrer\" target=\"_blank\">watchlist</a> or <a class=\"company-report-links\" data-vars-link-type=\"dcf_cta\" href=\"https://simplywall.st/features/portfolio\" rel=\"noopener noreferrer\" target=\"_blank\">portfolio</a> and be alerted when this changes, or use our stock screener to discover <a class=\"company-report-links\" data-vars-link-type=\"dcf_cta\" href=\"https://simplywall.st/discover/investing-ideas/473076/high-quality-undervalued-stocks/us\" rel=\"noopener noreferrer\" target=\"_blank\">53 high quality undervalued stocks</a>. If you <a class=\"company-report-links\" data-vars-link-type=\"dcf_cta\" href=\"https://simplywall.st/features/stock-screener\" rel=\"noopener noreferrer\" target=\"_blank\">save a screener</a> we even alert you when new companies match - so you never miss a potential opportunity.</p> <h2>Next Steps</h2> <p>Reading this, do you feel the story skews more upbeat or cautious? If you want to move quickly from headline impressions to your own judgment, it is worth weighing the key issues on both sides with <a class=\"company-report-links\" data-vars-link-type=\"cta_risks_rewards_analysis\" href=\"https://www.simplywall.st/stocks/us/capital-goods/nyse-ferg/ferguson-enterprises\" rel=\"noopener noreferrer\" target=\"_blank\">2 key rewards and 1 important warning sign</a>.</p> <h2>Looking for more investment ideas?</h2> <p>You have seen how one company stacks up. Now give yourself an edge by lining up a few more contenders and seeing which truly fit your plan.</p> <ul> <li>Spot potential value plays early by checking companies our screener flags as <a class=\"company-report-links\" data-vars-link-type=\"cta_screener_undiscovered_gems\" href=\"https://simplywall.st/discover/investing-ideas/473622/high-quality-undiscovered-gems/us\" rel=\"noopener noreferrer\" target=\"_blank\">screener containing 23 high quality undiscovered gems</a> with solid fundamentals that may not be widely followed yet.</li> <li>Strengthen the core of your portfolio using the <a class=\"company-report-links\" data-vars-link-type=\"cta_screener_solid_balance_sheet\" href=\"https://simplywall.st/discover/investing-ideas/10146/solid-balance-sheet-and-fundamentals/us\" rel=\"noopener noreferrer\" target=\"_blank\">solid balance sheet and fundamentals stocks screener (41 results)</a> to focus on businesses supported by healthier debt and liquidity profiles.</li> <li>Reduce portfolio stress by reviewing companies in the <a class=\"company-report-links\" data-vars-link-type=\"cta_screener_low_risk\" href=\"https://simplywall.st/discover/investing-ideas/473631/low-risk-leaders/us\" rel=\"noopener noreferrer\" target=\"_blank\">80 resilient stocks with low risk scores</a> that score well on stability and business quality, rather than relying only on headlines.</li> </ul> <p><em> This article by Simply Wall St is general in nature. <strong>We provide commentary based on historical data\n    and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice.</strong> It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your\n    financial situation. We aim to bring you long-term focused analysis driven by fundamental data.\n    Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material.\n    Simply Wall St has no position in any stocks mentioned.</em></p><div class=\"sc-80c0fb9d-0 hLZAWP\"><h3 class=\"m-0 text-balance text-mega font-medium mb-4 font-serif\"><strong>New: </strong>AI Stock Screener &amp; Alerts</h3><p>Our new AI Stock Screener scans the market every day to uncover opportunities.</p><p>‚Ä¢ Dividend Powerhouses (3%+ Yield)<br/>‚Ä¢ Undervalued Small Caps with Insider Buying<br/>‚Ä¢ High growth Tech and AI Companies<br/><br/>Or build your own from over 50 metrics.</p><a class=\"sc-kuACkN kjLJKA !text-[--s-button-primary-color-text] !no-underline\" data-focus=\"dashed\" href=\"https://simplywall.st/features/stock-screener\" target=\"_blank\">Explore Now for Free</a></div></div>",
            "pub_date": "2026-02-26 20:15:51",
            "link": "https://simplywall.st/stocks/us/capital-goods/nyse-ferg/ferguson-enterprises/news/assessing-ferguson-enterprises-ferg-valuation-after-a-year-o",
            "source": "simplywall",
            "kind": 1,
            "language": "en"
        },
        {
            "title": "Is Coupang (CPNG) Pricing Reflect Its South Korean E Commerce Strength After Recent Share Pullback",
            "description": "<div class=\"sc-d08486b0-3 byoTNg\" data-cy-id=\"article-content\"><ul> <li>If you are wondering whether Coupang's current share price really reflects what the business is worth, this article will walk through what the numbers are saying about value.</li> <li>The stock last closed at US$18.36, with returns of 1.7% over 7 days, a 6.2% decline over 30 days, a 21.4% decline year to date, and a 26.6% decline over 1 year. The 3 year return sits at 25.2%.</li> <li>Recent coverage has focused on Coupang's position in the South Korean e commerce market and how its scale and logistics network fit into long term expectations for online retail. This context has shaped how investors interpret the recent share price moves and the balance between growth potential and risk.</li> <li>On our checks, Coupang scores a <a class=\"company-report-links\" href=\"https://www.simplywall.st/stocks/us/retail/nyse-cpng/coupang/valuation\" rel=\"noopener noreferrer\" target=\"_blank\">2 out of 6 valuation score</a>, which raises some important questions about how it stacks up on different methods. We will look at those approaches next, then finish with a framework that can help you assess value more completely.</li> </ul> <p>Coupang scores just 2/6 on our valuation checks. See what other red flags we found in the <a class=\"company-report-links\" data-vars-link-type=\"cta_low_value_score\" href=\"https://www.simplywall.st/stocks/us/retail/nyse-cpng/coupang/valuation\" rel=\"noopener noreferrer\" target=\"_blank\">full valuation breakdown</a>.</p> <div class=\"relative grid grid-rows-[25px_auto] place-items-center bg-surface @container/article-body-ad [[data-brand='v2']_&amp;]:bg-surface-1\" data-cy-id=\"article-body-ad\"><div class=\"text-tiny text-softer\">Advertisement</div><div class=\"relative h-[250px] min-h-[250px] w-[300px] min-w-[300px] @[380px]/article-body-ad:h-[280px] @[380px]/article-body-ad:min-h-[280px] @[380px]/article-body-ad:w-[336px] @[380px]/article-body-ad:min-w-[336px]\"><div data-fuse=\"news_incontent_1\" id=\"news_incontent_1\"></div></div></div><h3>Approach 1: Coupang Discounted Cash Flow (DCF) Analysis</h3> <p>A Discounted Cash Flow, or DCF, model takes estimates of a company‚Äôs future cash flows and discounts them back to today using a required rate of return, to arrive at an estimate of what the business might be worth right now.</p> <p>For Coupang, the model uses a 2 Stage Free Cash Flow to Equity approach based on cash flow projections. The latest twelve month Free Cash Flow is about $1.27b. Analysts provide explicit Free Cash Flow estimates for the earlier years, and Simply Wall St then extrapolates further out, with projected Free Cash Flow of $2.89b in 2030. Each of these future cash flows is discounted back to today and added together.</p> <p>On this basis, the DCF output suggests an estimated intrinsic value of US$28.51 per share, compared with the recent share price of US$18.36. That gap implies the stock is 35.6% undervalued according to this model. This indicates a meaningful margin between price and estimated value.</p> <p><strong>Result: UNDERVALUED</strong></p> <p>Our Discounted Cash Flow (DCF) analysis suggests Coupang is undervalued by 35.6%. Track this in your <a class=\"company-report-links\" data-vars-link-type=\"cta_dcf_undervalued\" href=\"https://simplywall.st/features/stock-watchlist\" rel=\"noopener noreferrer\" target=\"_blank\">watchlist</a> or <a class=\"company-report-links\" data-vars-link-type=\"cta_dcf_undervalued\" href=\"https://simplywall.st/features/portfolio\" rel=\"noopener noreferrer\" target=\"_blank\">portfolio</a>, or discover <a class=\"company-report-links\" data-vars-link-type=\"cta_dcf_undervalued\" href=\"https://simplywall.st/discover/investing-ideas/473076/high-quality-undervalued-stocks/us\" rel=\"noopener noreferrer\" target=\"_blank\">53 more high quality undervalued stocks</a>.</p> <figure><a class=\"company-report-links\" data-vars-link-type=\"infographic\" href=\"https://www.simplywall.st//stocks/us/retail/nyse-cpng/coupang/valuation\" rel=\"noopener noreferrer\" target=\"_blank\"><img alt=\"CPNG Discounted Cash Flow as at Feb 2026\" class=\"sc-3204b94-0 iJdSPa\" height=\"476\" loading=\"lazy\" src=\"https://images.simplywall.st/company/92fa9f91-b6f0-4e02-abd0-a65beee4a53c/chart/dcf?date=2026-02-26\" width=\"746\"/></a><figcaption>CPNG Discounted Cash Flow as at Feb 2026</figcaption></figure> <p><a class=\"company-report-links\" data-vars-link-type=\"dcf_explainer_cta\" href=\"https://www.simplywall.st/stocks/us/retail/nyse-cpng/coupang/valuation\" rel=\"noopener noreferrer\" target=\"_blank\">Head to the Valuation section of our Company Report for more details on how we arrive at this Fair Value for Coupang.</a></p> <h3>Approach 2: Coupang Price vs Earnings</h3> <p>For profitable companies, the P/E ratio is a useful way to relate what you pay per share to the earnings the business is currently generating. It gives you a quick sense of how many dollars investors are willing to pay today for one dollar of current earnings.</p> <p>What counts as a ‚Äúnormal‚Äù P/E really depends on how the market views a company‚Äôs growth potential and risk. Higher expected growth or lower perceived risk can justify a higher P/E, while lower growth expectations or higher risk usually point to a lower P/E being reasonable.</p> <p>Coupang is trading on a P/E of 86x. That is well above the Multiline Retail industry average of 19.65x and also above the peer average of 28.99x. Simply Wall St‚Äôs Fair Ratio for Coupang, which is 36.15x, estimates what P/E might be appropriate after considering factors like earnings growth, industry, profit margins, market cap and specific risks.</p> <p>This Fair Ratio can be more informative than a simple comparison to peers or the industry because it adjusts for those company specific drivers instead of assuming one size fits all. With Coupang‚Äôs actual P/E of 86x versus the Fair Ratio of 36.15x, the shares screen as expensive on this metric.</p> <p><strong>Result: OVERVALUED</strong></p> <figure><a class=\"company-report-links\" data-vars-link-type=\"infographic\" href=\"https://www.simplywall.st//stocks/us/retail/nyse-cpng/coupang/valuation\" rel=\"noopener noreferrer\" target=\"_blank\"><img alt=\"NYSE:CPNG P/E Ratio as at Feb 2026\" class=\"sc-3204b94-0 iJdSPa\" height=\"476\" loading=\"lazy\" src=\"https://images.simplywall.st/company/92fa9f91-b6f0-4e02-abd0-a65beee4a53c/chart/pe-multiple-vs-industry?date=2026-02-26\" width=\"746\"/></a><figcaption>NYSE:CPNG P/E Ratio as at Feb 2026</figcaption></figure> <p>P/E ratios tell one story, but what if the real opportunity lies elsewhere? <a class=\"company-report-links\" data-vars-link-type=\"cta_preferred_multiple_contextual\" href=\"https://simplywall.st/discover/investing-ideas/473625/top-founder-led-companies/us\" rel=\"noopener noreferrer\" target=\"_blank\">Start investing in legacies, not executives. Discover our 21 top founder-led companies</a>.</p> <h3>Upgrade Your Decision Making: Choose your Coupang Narrative</h3> <p>Earlier we mentioned that there is an even better way to understand valuation, so let us introduce you to Narratives. This is a simple way for you to attach a clear story about Coupang‚Äôs future revenue, earnings and margins to a set of forecasts and a fair value. You can then compare that fair value to today‚Äôs price directly on Simply Wall St‚Äôs Community page, where Narratives are updated as new earnings or news arrives and can differ widely. For example, one Coupang Narrative may anchor around a fair value near the lower analyst end of about US$22.80 and another around the upper end near US$40.00. This gives you a structured way to decide how your own view lines up with the market.</p> <p>Do you think there's more to the story for Coupang? <a class=\"company-report-links\" data-vars-link-type=\"cta_create_narrative_community\" href=\"https://simplywall.st/stock/NYSE/CPNG\" rel=\"noopener noreferrer\" target=\"_blank\">Head over to our Community to see what others are saying!</a></p> <figure><a class=\"company-report-links\" data-vars-link-type=\"infographic\" href=\"https://www.simplywall.st//stocks/us/retail/nyse-cpng/coupang\" rel=\"noopener noreferrer\" target=\"_blank\"><img alt=\"NYSE:CPNG 1-Year Stock Price Chart\" class=\"sc-3204b94-0 iJdSPa\" height=\"476\" loading=\"lazy\" src=\"https://images.simplywall.st/company/92fa9f91-b6f0-4e02-abd0-a65beee4a53c/chart/quote-price?date=2026-02-26\" width=\"746\"/></a><figcaption>NYSE:CPNG 1-Year Stock Price Chart</figcaption></figure> <p><em> This article by Simply Wall St is general in nature. <strong>We provide commentary based on historical data\n    and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice.</strong> It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your\n    financial situation. We aim to bring you long-term focused analysis driven by fundamental data.\n    Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material.\n    Simply Wall St has no position in any stocks mentioned.</em></p><div class=\"sc-80c0fb9d-0 hLZAWP\"><h3 class=\"m-0 text-balance text-mega font-medium mb-4 font-serif\"><strong>New: </strong>AI Stock Screener &amp; Alerts</h3><p>Our new AI Stock Screener scans the market every day to uncover opportunities.</p><p>‚Ä¢ Dividend Powerhouses (3%+ Yield)<br/>‚Ä¢ Undervalued Small Caps with Insider Buying<br/>‚Ä¢ High growth Tech and AI Companies<br/><br/>Or build your own from over 50 metrics.</p><a class=\"sc-kuACkN kjLJKA !text-[--s-button-primary-color-text] !no-underline\" data-focus=\"dashed\" href=\"https://simplywall.st/features/stock-screener\" target=\"_blank\">Explore Now for Free</a></div></div>",
            "pub_date": "2026-02-26 20:15:51",
            "link": "https://simplywall.st/stocks/us/retail/nyse-cpng/coupang/news/is-coupang-cpng-pricing-reflect-its-south-korean-e-commerce",
            "source": "simplywall",
            "kind": 1,
            "language": "en"
        },
        {
            "title": "Uber Air, SpotHero And Robotaxis Expand Uber‚Äôs Mobility And Valuation Story",
            "description": "<div class=\"sc-d08486b0-3 byoTNg\" data-cy-id=\"article-content\"><ul> <li>Uber Technologies (NYSE:UBER) is rolling out Uber Air powered by Joby, bringing electric air taxis into its platform as a new aerial ride hailing option.</li> <li>The company is acquiring parking platform SpotHero to let users reserve parking directly within the Uber app.</li> <li>Uber is also formally launching Uber Autonomous Solutions to support and scale robotaxi deployments across global markets.</li> </ul> <p>For you as an investor, these moves show how Uber is pushing beyond its core ridesharing and food delivery services into a broader mobility platform that spans ground, air and autonomous transport. Electric air taxis, app based parking and driverless rides all sit within major industry themes around electrification, automation and integrated trip planning. NYSE:UBER is positioning itself at several of those junctions at once.</p> <p>Looking ahead, the key questions will be how quickly these offerings gain real world usage, how regulators treat new air and autonomous services, and how economics compare with traditional ride hailing. As these initiatives progress, investors may focus on metrics such as adoption, partnership depth and unit economics rather than treating them as purely experimental projects.</p> <p>Stay updated on the most important news stories for <a class=\"company-report-links\" data-vars-link-type=\"news_stay_updated_cta\" href=\"https://www.simplywall.st/stocks/us/transportation/nyse-uber/uber-technologies/valuation\" rel=\"noopener noreferrer\" target=\"_blank\">Uber Technologies</a> by adding it to your <a class=\"company-report-links\" data-vars-link-type=\"news_stay_updated_cta\" href=\"https://simplywall.st/features/stock-watchlist\" rel=\"noopener noreferrer\" target=\"_blank\">watchlist</a> or <a class=\"company-report-links\" data-vars-link-type=\"news_stay_updated_cta\" href=\"https://simplywall.st/features/portfolio\" rel=\"noopener noreferrer\" target=\"_blank\">portfolio</a>. Alternatively, explore our <a class=\"company-report-links\" data-vars-link-type=\"news_stay_updated_cta\" href=\"https://simplywall.st/stock/NYSE/UBER\" rel=\"noopener noreferrer\" target=\"_blank\">Community</a> to discover new perspectives on Uber Technologies.</p> <figure><a class=\"company-report-links\" data-vars-link-type=\"infographic\" href=\"https://www.simplywall.st/stocks/us/transportation/nyse-uber/uber-technologies/future\" rel=\"noopener noreferrer\" target=\"_blank\"><img alt=\"NYSE:UBER Earnings &amp; Revenue Growth as at Feb 2026\" class=\"sc-3204b94-0 iJdSPa\" height=\"476\" loading=\"lazy\" src=\"https://images.simplywall.st/company/57147e6d-cf28-4e13-b807-86a31e002d9b/chart/earnings-and-revenue-growth?date=2026-02-26\" width=\"746\"/></a><figcaption>NYSE:UBER Earnings &amp; Revenue Growth as at Feb 2026</figcaption></figure> <p><a class=\"company-report-links\" data-vars-link-type=\"cta_news_full_picture\" href=\"https://www.simplywall.st/stocks/us/transportation/nyse-uber/uber-technologies\" rel=\"noopener noreferrer\" target=\"_blank\">üì∞ Beyond the headline: 0 risks and 5 things going right for Uber Technologies that every investor should see.</a></p> <div class=\"relative grid grid-rows-[25px_auto] place-items-center bg-surface @container/article-body-ad [[data-brand='v2']_&amp;]:bg-surface-1\" data-cy-id=\"article-body-ad\"><div class=\"text-tiny text-softer\">Advertisement</div><div class=\"relative h-[250px] min-h-[250px] w-[300px] min-w-[300px] @[380px]/article-body-ad:h-[280px] @[380px]/article-body-ad:min-h-[280px] @[380px]/article-body-ad:w-[336px] @[380px]/article-body-ad:min-w-[336px]\"><div data-fuse=\"news_incontent_1\" id=\"news_incontent_1\"></div></div></div><h3>Quick Assessment</h3> <ul> <li><strong>‚úÖ Price vs Analyst Target</strong>: At US$72.83 versus an average analyst target of US$104.47, the price sits roughly 30% below consensus.</li> <li><strong>‚úÖ Simply Wall St Valuation</strong>: Uber Technologies is described as trading about 57.5% below an estimated fair value.</li> <li><strong>‚ùå Recent Momentum</strong>: The 30 day return of about 11.2% decline shows recent weakness despite the new growth initiatives.</li> </ul> <p>There is only one way to know the right time to buy, sell or hold Uber Technologies. Head to Simply Wall St's\n<a class=\"company-report-links\" href=\"https://www.simplywall.st/stocks/us/transportation/nyse-uber/uber-technologies/valuation\" rel=\"noopener noreferrer\" target=\"_blank\">company report for the latest analysis of Uber Technologies's Fair Value</a>.</p> <h3>Key Considerations</h3> <ul> <li>üìä Uber Air, SpotHero and Autonomous Solutions extend the business into air taxis, parking and robotaxis, all of which sit on top of the existing US$52.0b revenue base.</li> <li>üìä Keep an eye on adoption, regulatory approvals, partnership activity and how these bets affect metrics like margins, a P/E of 14.9 and the current discount to analyst targets.</li> <li>‚ö†Ô∏è Execution and regulatory risk around air mobility and autonomy is high, so the timing and scale of any financial contribution is uncertain.</li> </ul> <h3>Dig Deeper</h3> <p>For the full picture including more risks and rewards, check out the\n<a class=\"company-report-links\" href=\"https://www.simplywall.st/stocks/us/transportation/nyse-uber/uber-technologies\" rel=\"noopener noreferrer\" target=\"_blank\">complete Uber Technologies analysis</a>. Alternatively, you can visit the\n<a class=\"company-report-links\" href=\"https://www.simplywall.st/stock/NYSE/UBER\" rel=\"noopener noreferrer\" target=\"_blank\">community page for Uber Technologies</a> to see how other investors believe this latest news will impact the company's narrative.</p> <p><em> This article by Simply Wall St is general in nature. <strong>We provide commentary based on historical data\n    and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice.</strong> It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your\n    financial situation. We aim to bring you long-term focused analysis driven by fundamental data.\n    Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material.\n    Simply Wall St has no position in any stocks mentioned.</em></p><div class=\"sc-80c0fb9d-0 hLZAWP\"><h3 class=\"m-0 text-balance text-mega font-medium mb-4 font-serif\"><strong>New: </strong>AI Stock Screener &amp; Alerts</h3><p>Our new AI Stock Screener scans the market every day to uncover opportunities.</p><p>‚Ä¢ Dividend Powerhouses (3%+ Yield)<br/>‚Ä¢ Undervalued Small Caps with Insider Buying<br/>‚Ä¢ High growth Tech and AI Companies<br/><br/>Or build your own from over 50 metrics.</p><a class=\"sc-kuACkN kjLJKA !text-[--s-button-primary-color-text] !no-underline\" data-focus=\"dashed\" href=\"https://simplywall.st/features/stock-screener\" target=\"_blank\">Explore Now for Free</a></div></div>",
            "pub_date": "2026-02-26 20:15:50",
            "link": "https://simplywall.st/stocks/us/transportation/nyse-uber/uber-technologies/news/uber-air-spothero-and-robotaxis-expand-ubers-mobility-and-va",
            "source": "simplywall",
            "kind": 1,
            "language": "en"
        },
        {
            "title": "Corcept Therapeutics (CORT) Margin Compression Reinforces Bearish Narrative Despite FY 2025 Revenue Strength",
            "description": "<div class=\"sc-d08486b0-3 byoTNg\" data-cy-id=\"article-content\"><div class=\"relative grid grid-rows-[25px_auto] place-items-center bg-surface @container/article-body-ad [[data-brand='v2']_&amp;]:bg-surface-1\" data-cy-id=\"article-body-ad\"><div class=\"text-tiny text-softer\">Advertisement</div><div class=\"relative h-[250px] min-h-[250px] w-[300px] min-w-[300px] @[380px]/article-body-ad:h-[280px] @[380px]/article-body-ad:min-h-[280px] @[380px]/article-body-ad:w-[336px] @[380px]/article-body-ad:min-w-[336px]\"><div data-fuse=\"news_incontent_1\" id=\"news_incontent_1\"></div></div></div><h2>Corcept Therapeutics FY 2025 earnings snapshot</h2> <p>Corcept Therapeutics (CORT) has wrapped up FY 2025 with Q4 revenue of US$202.1 million and basic EPS of US$0.24, alongside net income of US$25.4 million. Over the past six quarters, the company has seen revenue move from US$181.9 million in Q4 2024 to a range between US$157.2 million and US$207.6 million per quarter, while basic EPS has ranged between US$0.19 and US$0.45. With a trailing 12 month net profit margin of 13.1% compared to 20.7% a year earlier, investors are likely to focus on how the latest results balance growth with pressure on profitability.</p> <a class=\"company-report-links\" data-vars-link-type=\"cta_company_latest_analysis_earnings\" href=\"https://www.simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-cort/corcept-therapeutics\" rel=\"noopener noreferrer\" target=\"_blank\">See our full analysis for Corcept Therapeutics.</a> <p>With the headline numbers on the table, the next step is to set these results against the most widely held narratives about Corcept to see where the data supports the story and where it challenges expectations.</p> <p><a class=\"company-report-links\" data-vars-link-type=\"cta_range_narrative\" href=\"https://www.simplywall.st/narratives/k8j44tpe-corcept-and-its-fair-value-according-my-dcf-valuation\" rel=\"noopener noreferrer\" target=\"_blank\">See what the community is saying about Corcept Therapeutics</a></p> <figure><a class=\"company-report-links\" data-vars-link-type=\"infographic\" href=\"https://www.simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-cort/corcept-therapeutics/past\" rel=\"noopener noreferrer\" target=\"_blank\"><img alt=\"NasdaqCM:CORT Revenue &amp; Expenses Breakdown as at Feb 2026\" class=\"sc-3204b94-0 iJdSPa\" height=\"476\" loading=\"lazy\" src=\"https://images.simplywall.st/company/9debd0be-0e12-4a5b-bb89-86d4785ce898/chart/revenue-and-expenses-breakdown?date=2026-02-26\" width=\"746\"/></a><figcaption>NasdaqCM:CORT Revenue &amp; Expenses Breakdown as at Feb 2026</figcaption></figure> <h2>Margins Under Pressure As Net Profit Slides To US$99.7 Million</h2> <ul> <li>On a trailing 12 month basis, net income is US$99.7 million on US$761.4 million of revenue, which lines up with the 13.1% net margin mentioned earlier compared with 20.7% a year ago.</li> <li>Bears point to this margin compression as a key risk, and the recent numbers back up part of that concern:\n    <ul> <li>Net income over the last 12 months, at US$99.7 million, is below the US$139.7 million level a year earlier, even though trailing revenue increased from US$675.0 million to US$761.4 million.</li> <li>This mix of higher sales and lower profitability fits the bearish argument that rising R&amp;D and SG&amp;A to support the pipeline and commercial build out could keep net margins under pressure.</li> </ul> </li> </ul> <p>Skeptics warn that if costs keep climbing faster than revenue, future approvals may not translate cleanly into stronger bottom line results. <a class=\"company-report-links\" data-vars-link-type=\"cta_bear_narrative_link\" href=\"https://simplywall.st/narratives/hjr4jqq6-update-for-corcept-therapeutics\" rel=\"noopener noreferrer\" target=\"_blank\"><strong>üêª Corcept Therapeutics Bear Case</strong></a></p> <h2>Revenue Near US$761 Million Backs High-Growth Story</h2> <ul> <li>Trailing 12 month revenue has reached US$761.4 million, up from US$628.6 million six quarters ago, and is characterized as growing around 21% annually, faster than the broader US market rate of 10.4% cited in the analysis.</li> <li>Supporters of the bullish view argue that this revenue base, combined with the pipeline, sets up strong earnings expansion:\n    <ul> <li>Trailing EPS of US$0.96 per share sits on that higher revenue level, and analysts are cited as expecting earnings to grow around 44.7% per year from here.</li> <li>Bulls tie that growth outlook to potential new indications in hypercortisolism and oncology, suggesting that today‚Äôs revenue run rate may be only a starting point if key trials and approvals play out as they expect.</li> </ul> </li> </ul> <p>Bulls argue that if Corcept can convert its late stage pipeline into approved products, the current revenue base could look conservative in hindsight. <a class=\"company-report-links\" data-vars-link-type=\"cta_bull_narrative_link\" href=\"https://simplywall.st/narratives/ieqy8pxg-update-for-corcept-therapeutics\" rel=\"noopener noreferrer\" target=\"_blank\"><strong>üêÇ Corcept Therapeutics Bull Case</strong></a></p> <h2>Premium 38.7x P/E Versus DCF Fair Value Of About US$325</h2> <ul> <li>The shares trade at a trailing P/E of 38.7x on a price of US$36.22, above both the peer average of 34.8x and the US Pharmaceuticals industry average of 19.9x, while an internal DCF fair value estimate sits much higher at about US$324.99.</li> <li>This combination creates a split between bulls and bears on valuation:\n    <ul> <li>Critics highlight the premium P/E against industry and peers as a sign that a lot of the future growth story is already reflected in the multiple, especially with trailing net margin at 13.1% versus 20.7% a year ago.</li> <li>Supporters point to the large gap between the current share price of US$36.22 and the cited DCF fair value near US$325 as evidence that the market is not fully reflecting the forecast earnings growth and pipeline potential.</li> </ul> </li> </ul> <h2>Next Steps</h2> <p>To see how these results tie into long-term growth, risks, and valuation, check out the full range of <a class=\"company-report-links\" data-vars-link-type=\"conclusion_cta_when_narratives_exist\" href=\"https://www.simplywall.st/narratives/k8j44tpe-corcept-and-its-fair-value-according-my-dcf-valuation\" rel=\"noopener noreferrer\" target=\"_blank\">community narratives</a> for Corcept Therapeutics on Simply Wall St. Add the company to your <a class=\"company-report-links\" data-vars-link-type=\"conclusion_cta_when_narratives_exist\" href=\"https://simplywall.st/features/stock-watchlist\" rel=\"noopener noreferrer\" target=\"_blank\">watchlist</a> or <a class=\"company-report-links\" data-vars-link-type=\"conclusion_cta_when_narratives_exist\" href=\"https://simplywall.st/features/portfolio\" rel=\"noopener noreferrer\" target=\"_blank\">portfolio</a> so you'll be alerted when the story evolves.</p> <p>With both optimism and concern running through this story, it makes sense to check the underlying data yourself and move quickly to form your own stance. To see how the positives stack up against the downsides, take a look at the <a class=\"company-report-links\" data-vars-link-type=\"cta_risks_rewards_analysis\" href=\"https://www.simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-cort/corcept-therapeutics\" rel=\"noopener noreferrer\" target=\"_blank\">2 key rewards and 2 important warning signs</a>.</p> <h2>See What Else Is Out There</h2> <p>Corcept's shrinking net margin, a premium 38.7x P/E, and lower trailing net income than a year ago put pressure on the valuation story.</p> <p>If that mix of high expectations and margin strain feels uncomfortable, you may want to balance your watchlist with <a class=\"company-report-links\" data-vars-link-type=\"cta_screener_low_risk\" href=\"https://simplywall.st/discover/investing-ideas/473631/low-risk-leaders/us\" rel=\"noopener noreferrer\" target=\"_blank\">80 resilient stocks with low risk scores</a> that aim to keep volatility and downside in check.</p> <p><em> This article by Simply Wall St is general in nature. <strong>We provide commentary based on historical data\n    and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice.</strong> It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your\n    financial situation. We aim to bring you long-term focused analysis driven by fundamental data.\n    Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material.\n    Simply Wall St has no position in any stocks mentioned.</em></p><div class=\"sc-80c0fb9d-0 hLZAWP\"><h3 class=\"m-0 text-balance text-mega font-medium mb-4 font-serif\"><strong>New: </strong>AI Stock Screener &amp; Alerts</h3><p>Our new AI Stock Screener scans the market every day to uncover opportunities.</p><p>‚Ä¢ Dividend Powerhouses (3%+ Yield)<br/>‚Ä¢ Undervalued Small Caps with Insider Buying<br/>‚Ä¢ High growth Tech and AI Companies<br/><br/>Or build your own from over 50 metrics.</p><a class=\"sc-kuACkN kjLJKA !text-[--s-button-primary-color-text] !no-underline\" data-focus=\"dashed\" href=\"https://simplywall.st/features/stock-screener\" target=\"_blank\">Explore Now for Free</a></div></div>",
            "pub_date": "2026-02-26 20:15:50",
            "link": "https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-cort/corcept-therapeutics/news/corcept-therapeutics-cort-margin-compression-reinforces-bear",
            "source": "simplywall",
            "kind": 1,
            "language": "en"
        },
        {
            "title": "Fastenal CEO Pay Jump, Insider Buying And Contracts Reshape Investment Story",
            "description": "<div class=\"sc-d08486b0-3 byoTNg\" data-cy-id=\"article-content\"><ul> <li>Fastenal (NasdaqGS:FAST) reported a nearly 60% year over year increase in CEO compensation.</li> <li>Company insiders have been purchasing additional shares of Fastenal stock.</li> <li>Fastenal secured almost US$8 million in government contract awards.</li> </ul> <p>Fastenal, a major distributor of industrial and construction supplies, sits at the intersection of manufacturing, construction, and maintenance activity across North America. For investors, shifts in executive pay, insider trading activity, and government contract wins can be just as important as headline earnings because they help you understand how the people running the business are positioning it.</p> <p>The combination of higher CEO compensation, insider buying, and fresh government work gives you more data points to weigh alongside your existing view on NasdaqGS:FAST. These developments may inform how you think about management priorities, capital allocation, and the stability of public sector demand as you assess where the company might fit in your portfolio over the long term.</p> <p>Stay updated on the most important news stories for <a class=\"company-report-links\" data-vars-link-type=\"news_stay_updated_cta\" href=\"https://www.simplywall.st/stocks/us/capital-goods/nasdaq-fast/fastenal/valuation\" rel=\"noopener noreferrer\" target=\"_blank\">Fastenal</a> by adding it to your <a class=\"company-report-links\" data-vars-link-type=\"news_stay_updated_cta\" href=\"https://simplywall.st/features/stock-watchlist\" rel=\"noopener noreferrer\" target=\"_blank\">watchlist</a> or <a class=\"company-report-links\" data-vars-link-type=\"news_stay_updated_cta\" href=\"https://simplywall.st/features/portfolio\" rel=\"noopener noreferrer\" target=\"_blank\">portfolio</a>. Alternatively, explore our <a class=\"company-report-links\" data-vars-link-type=\"news_stay_updated_cta\" href=\"https://simplywall.st/stock/NasdaqGS/FAST\" rel=\"noopener noreferrer\" target=\"_blank\">Community</a> to discover new perspectives on Fastenal.</p> <figure><a class=\"company-report-links\" data-vars-link-type=\"infographic\" href=\"https://www.simplywall.st//stocks/us/capital-goods/nasdaq-fast/fastenal\" rel=\"noopener noreferrer\" target=\"_blank\"><img alt=\"NasdaqGS:FAST 1-Year Stock Price Chart\" class=\"sc-3204b94-0 iJdSPa\" height=\"476\" loading=\"lazy\" src=\"https://images.simplywall.st/company/586d6a07-e1e7-43fc-b9c0-9f2e6acf9d5e/chart/quote-price?date=2026-02-26\" width=\"746\"/></a><figcaption>NasdaqGS:FAST 1-Year Stock Price Chart</figcaption></figure> <p><a class=\"company-report-links\" data-vars-link-type=\"cta_news_ownership\" href=\"https://www.simplywall.st/stocks/us/capital-goods/nasdaq-fast/fastenal/ownership\" rel=\"noopener noreferrer\" target=\"_blank\">See which insiders are buying and buying and selling Fastenal following this latest news.</a></p> <p>For you as a shareholder or potential investor, the combination of a roughly 59% jump in CEO pay, insider share purchases, and close to US$8m in government contract awards sends mixed but useful signals. Higher compensation often reflects board confidence in management after a solid year, and Fastenal did report double digit daily sales growth and market share gains in 2025. At the same time, insider buying can suggest that executives and directors are comfortable owning more stock at current prices, which some investors read as a sign that internal expectations remain constructive.</p> <div class=\"relative grid grid-rows-[25px_auto] place-items-center bg-surface @container/article-body-ad [[data-brand='v2']_&amp;]:bg-surface-1\" data-cy-id=\"article-body-ad\"><div class=\"text-tiny text-softer\">Advertisement</div><div class=\"relative h-[250px] min-h-[250px] w-[300px] min-w-[300px] @[380px]/article-body-ad:h-[280px] @[380px]/article-body-ad:min-h-[280px] @[380px]/article-body-ad:w-[336px] @[380px]/article-body-ad:min-w-[336px]\"><div data-fuse=\"news_incontent_1\" id=\"news_incontent_1\"></div></div></div><h3>How This Fits Into The Fastenal Narrative</h3> <ul> <li>The higher CEO compensation and insider buying sit alongside Fastenal‚Äôs push into digital sales and Fastenal Managed Inventory technology, which management has highlighted as central to growth and margin resilience.</li> <li>Rising executive pay could be questioned if future margins or growth fall short of what is needed to support the company‚Äôs investments in supply-chain diversification and on-site distribution.</li> <li>The nearly US$8m in government contracts adds a public-sector angle that is not a major focus of the existing narrative, which has centered more on large industrial customers and digital channels.</li> </ul> <p>Knowing what a company is worth starts with understanding its story.\n<a class=\"company-report-links\" data-vars-link-type=\"integrated-pitch\" href=\"https://simplywall.st/narratives/ei8gojit-digital-solutions-and-resilient-supply-chains-will-drive-future-strength-ghav\" rel=\"noopener noreferrer\" target=\"_blank\">Check out one of the top narratives in the Simply Wall St Community for Fastenal</a> to help decide what it's worth to you.</p> <h3>The Risks and Rewards Investors Should Consider</h3> <ul> <li>‚ö†Ô∏è A large increase in CEO compensation could become a concern if future performance does not align with pay, especially compared with peers like W.W. Grainger or MSC Industrial.</li> <li>‚ö†Ô∏è Analysts have flagged at least one risk, including questions around dividend cover by free cash flow, which may influence how you think about capital returns versus reinvestment.</li> <li>üéÅ Insider share purchases over the past six months may indicate confidence from those closest to the business in Fastenal‚Äôs direction and execution.</li> <li>üéÅ Additional government contracts can help diversify revenue sources and provide more visibility on a portion of sales alongside existing industrial customers.</li> </ul> <h3>What To Watch Going Forward</h3> <p>From here, you may want to track whether insider buying continues, how executive pay trends relative to sales, earnings, and cash flow, and whether Fastenal wins more national or government contracts that complement its digital and on-site offerings. Comparing Fastenal‚Äôs progress and governance practices with distributors like W.W. Grainger and MSC Industrial can also help you judge whether the compensation and contract trends are aligned with long-term value creation.</p> <p>To keep up with how the latest news impacts the investment narrative for Fastenal, visit the\n<a class=\"company-report-links\" href=\"https://www.simplywall.st/stock/NasdaqGS/FAST\" rel=\"noopener noreferrer\" target=\"_blank\">community page for Fastenal</a> to stay updated on the top community narratives.</p> <p><em> This article by Simply Wall St is general in nature. <strong>We provide commentary based on historical data\n    and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice.</strong> It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your\n    financial situation. We aim to bring you long-term focused analysis driven by fundamental data.\n    Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material.\n    Simply Wall St has no position in any stocks mentioned.</em></p><div class=\"sc-80c0fb9d-0 hLZAWP\"><h3 class=\"m-0 text-balance text-mega font-medium mb-4 font-serif\"><strong>New: </strong>AI Stock Screener &amp; Alerts</h3><p>Our new AI Stock Screener scans the market every day to uncover opportunities.</p><p>‚Ä¢ Dividend Powerhouses (3%+ Yield)<br/>‚Ä¢ Undervalued Small Caps with Insider Buying<br/>‚Ä¢ High growth Tech and AI Companies<br/><br/>Or build your own from over 50 metrics.</p><a class=\"sc-kuACkN kjLJKA !text-[--s-button-primary-color-text] !no-underline\" data-focus=\"dashed\" href=\"https://simplywall.st/features/stock-screener\" target=\"_blank\">Explore Now for Free</a></div></div>",
            "pub_date": "2026-02-26 20:10:47",
            "link": "https://simplywall.st/stocks/us/capital-goods/nasdaq-fast/fastenal/news/fastenal-ceo-pay-jump-insider-buying-and-contracts-reshape-i",
            "source": "simplywall",
            "kind": 1,
            "language": "en"
        },
        {
            "title": "A Look At LeMaitre Vascular (LMAT) Valuation After Recent Share Price Momentum",
            "description": "<div class=\"sc-d08486b0-3 byoTNg\" data-cy-id=\"article-content\"><div class=\"relative grid grid-rows-[25px_auto] place-items-center bg-surface @container/article-body-ad [[data-brand='v2']_&amp;]:bg-surface-1\" data-cy-id=\"article-body-ad\"><div class=\"text-tiny text-softer\">Advertisement</div><div class=\"relative h-[250px] min-h-[250px] w-[300px] min-w-[300px] @[380px]/article-body-ad:h-[280px] @[380px]/article-body-ad:min-h-[280px] @[380px]/article-body-ad:w-[336px] @[380px]/article-body-ad:min-w-[336px]\"><div data-fuse=\"news_incontent_1\" id=\"news_incontent_1\"></div></div></div><h2>Event driven snapshot of LeMaitre Vascular</h2> <p>LeMaitre Vascular (LMAT) has drawn investor attention after recent share price moves, with the stock last closing at $91.38, prompting a closer look at how its fundamentals line up with current market pricing.</p> <p><a class=\"company-report-links\" data-vars-link-type=\"cta_company_latest_analysis\" href=\"https://www.simplywall.st/stocks/us/healthcare/nasdaq-lmat/lemaitre-vascular\" rel=\"noopener noreferrer\" target=\"_blank\">See our latest analysis for LeMaitre Vascular.</a></p> <p>At $91.38, LeMaitre Vascular‚Äôs recent momentum has been relatively firm, with a 30 day share price return of 7.15% and a year to date share price return of 13.98%. This comes even though the 1 year total shareholder return is a 10.50% loss, while the 3 and 5 year total shareholder returns of 86.83% and 88.55% point to a much stronger longer term picture.</p> <p>If this move in a specialized healthcare name has you thinking about where else growth themes might emerge, it could be worth scanning our list of <a class=\"company-report-links\" data-vars-link-type=\"cta_screener_healthcare_ai\" href=\"https://simplywall.st/discover/investing-ideas/434426/healthcare-ai/us\" rel=\"noopener noreferrer\" target=\"_blank\">30 healthcare AI stocks</a> as another potential hunting ground.</p> <p>So with LeMaitre Vascular showing solid multi year total returns, growing revenue and net income, and trading at $91.38, is the current price leaving meaningful upside on the table, or is the market already factoring in future growth?</p> <h2>Most Popular Narrative: 12.8% Undervalued</h2> <p>On the most followed narrative, LeMaitre Vascular‚Äôs fair value sits at $104.78 versus the last close of $91.38. This sets up a valuation gap that hinges on future growth and margins.</p> <blockquote> <p><em>Strong pipeline of biologics and next-generation products, combined with ongoing regulatory wins, enhances pricing power and product mix; this supports premium pricing and improved gross margins, with successful launches expected to materially contribute to long-term earnings growth.</em></p> </blockquote> <p><em><a class=\"company-report-links\" data-vars-link-type=\"cta_narrative_prompt_after_quote\" href=\"https://www.simplywall.st/narratives/ihxgc0hy-european-and-global-demographics-will-expand-minimally-invasive-care-wrzv\" rel=\"noopener noreferrer\" target=\"_blank\">Read the complete narrative.</a></em></p> <p>Curious what kind of revenue trajectory and margin profile investors are baking into that fair value, and how those cash flows stack up once discounted? The full narrative lays out a detailed earnings path, a tighter share count assumption, and a premium multiple that together need to hold for $104.78 to make sense.</p> <p><strong>Result: Fair Value of $104.78 (UNDERVALUED)</strong></p> <p><a class=\"company-report-links\" data-vars-link-type=\"cta_ai_narrative\" href=\"https://www.simplywall.st/narratives/ihxgc0hy-european-and-global-demographics-will-expand-minimally-invasive-care-wrzv\" rel=\"noopener noreferrer\" target=\"_blank\">Have a read of the narrative in full and understand what's behind the forecasts.</a></p> <p>However, this hinges on pricing power and international execution. Any pullback in price increases or regulatory setbacks could quickly challenge that 12.8% undervalued case.</p> <p><a class=\"company-report-links\" data-vars-link-type=\"risks_narrative_cta\" href=\"https://www.simplywall.st/stocks/us/healthcare/nasdaq-lmat/lemaitre-vascular\" rel=\"noopener noreferrer\" target=\"_blank\">Find out about the key risks to this LeMaitre Vascular narrative.</a></p> <h2>Another View: Cash Flows Paint A Different Picture</h2> <p>That 12.8% undervalued story contrasts with our DCF model, which puts LeMaitre Vascular‚Äôs fair value at $66.87 versus the current $91.38. On this view, the shares screen as expensive. The key question is which set of growth and margin assumptions you trust more.</p> <p><a class=\"company-report-links\" data-vars-link-type=\"alternate_dcf_cta\" href=\"https://www.simplywall.st/stocks/us/healthcare/nasdaq-lmat/lemaitre-vascular/valuation\" rel=\"noopener noreferrer\" target=\"_blank\">Look into how the SWS DCF model arrives at its fair value.</a></p> <p></p><figure><a class=\"company-report-links\" data-vars-link-type=\"infographic\" href=\"https://www.simplywall.st//stocks/us/healthcare/nasdaq-lmat/lemaitre-vascular/valuation\" rel=\"noopener noreferrer\" target=\"_blank\"><img alt=\"LMAT Discounted Cash Flow as at Feb 2026\" class=\"sc-3204b94-0 iJdSPa\" height=\"476\" loading=\"lazy\" src=\"https://images.simplywall.st/company/2536c0b3-c39e-4a97-aad0-564339d2e0be/chart/dcf?date=2026-02-26\" width=\"746\"/></a><figcaption>LMAT Discounted Cash Flow as at Feb 2026</figcaption></figure><p> </p><p>Simply Wall St performs a discounted cash flow (DCF) on every stock in the world every day (<a class=\"company-report-links\" data-vars-link-type=\"dcf_cta\" href=\"https://www.simplywall.st/stocks/us/healthcare/nasdaq-lmat/lemaitre-vascular\" rel=\"noopener noreferrer\" target=\"_blank\">check out LeMaitre Vascular for example</a>). We show the entire calculation in full. You can track the result in your <a class=\"company-report-links\" data-vars-link-type=\"dcf_cta\" href=\"https://simplywall.st/features/stock-watchlist\" rel=\"noopener noreferrer\" target=\"_blank\">watchlist</a> or <a class=\"company-report-links\" data-vars-link-type=\"dcf_cta\" href=\"https://simplywall.st/features/portfolio\" rel=\"noopener noreferrer\" target=\"_blank\">portfolio</a> and be alerted when this changes, or use our stock screener to discover <a class=\"company-report-links\" data-vars-link-type=\"dcf_cta\" href=\"https://simplywall.st/discover/investing-ideas/473076/high-quality-undervalued-stocks/us\" rel=\"noopener noreferrer\" target=\"_blank\">53 high quality undervalued stocks</a>. If you <a class=\"company-report-links\" data-vars-link-type=\"dcf_cta\" href=\"https://simplywall.st/features/stock-screener\" rel=\"noopener noreferrer\" target=\"_blank\">save a screener</a> we even alert you when new companies match - so you never miss a potential opportunity.</p> <h2>Next Steps</h2> <p>If this mix of optimism and caution has you weighing both sides, it is worth checking the numbers yourself and deciding quickly where you stand. A good place to start is <a class=\"company-report-links\" data-vars-link-type=\"cta_rewards_analysis\" href=\"https://www.simplywall.st/stocks/us/healthcare/nasdaq-lmat/lemaitre-vascular\" rel=\"noopener noreferrer\" target=\"_blank\">2 key rewards</a>.</p> <h2>Looking for more investment ideas?</h2> <p>If you are weighing up LeMaitre Vascular, do not stop here. The screener can quickly surface other ideas that fit your style before the next move happens.</p> <ul> <li>Target dependable income by scanning for companies in our list of <a class=\"company-report-links\" data-vars-link-type=\"cta_screener_dividend\" href=\"https://simplywall.st/discover/investing-ideas/473528/dividend-fortresses/us\" rel=\"noopener noreferrer\" target=\"_blank\">15 dividend fortresses</a> that combine higher yields with a focus on resilience.</li> <li>Hunt for potential mispriced opportunities using our <a class=\"company-report-links\" data-vars-link-type=\"cta_screener_undervalued\" href=\"https://simplywall.st/discover/investing-ideas/473076/high-quality-undervalued-stocks/us\" rel=\"noopener noreferrer\" target=\"_blank\">53 high quality undervalued stocks</a> and see which names line up with your own expectations for quality and price.</li> <li>Prioritize capital preservation by filtering for <a class=\"company-report-links\" data-vars-link-type=\"cta_screener_low_risk\" href=\"https://simplywall.st/discover/investing-ideas/473631/low-risk-leaders/us\" rel=\"noopener noreferrer\" target=\"_blank\">80 resilient stocks with low risk scores</a> that aim to balance growth potential with lower overall risk profiles.</li> </ul> <p><em> This article by Simply Wall St is general in nature. <strong>We provide commentary based on historical data\n    and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice.</strong> It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your\n    financial situation. We aim to bring you long-term focused analysis driven by fundamental data.\n    Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material.\n    Simply Wall St has no position in any stocks mentioned.</em></p><div class=\"sc-80c0fb9d-0 hLZAWP\"><h3 class=\"m-0 text-balance text-mega font-medium mb-4 font-serif\"><strong>New: </strong>AI Stock Screener &amp; Alerts</h3><p>Our new AI Stock Screener scans the market every day to uncover opportunities.</p><p>‚Ä¢ Dividend Powerhouses (3%+ Yield)<br/>‚Ä¢ Undervalued Small Caps with Insider Buying<br/>‚Ä¢ High growth Tech and AI Companies<br/><br/>Or build your own from over 50 metrics.</p><a class=\"sc-kuACkN kjLJKA !text-[--s-button-primary-color-text] !no-underline\" data-focus=\"dashed\" href=\"https://simplywall.st/features/stock-screener\" target=\"_blank\">Explore Now for Free</a></div></div>",
            "pub_date": "2026-02-26 20:10:47",
            "link": "https://simplywall.st/stocks/us/healthcare/nasdaq-lmat/lemaitre-vascular/news/a-look-at-lemaitre-vascular-lmat-valuation-after-recent-shar-1",
            "source": "simplywall",
            "kind": 1,
            "language": "en"
        },
        {
            "title": "Is NAB‚Äôs Strong Q1 Profit and New CFO Shaping a Different Long‚ÄëTerm Case for ASX:NAB?",
            "description": "<div class=\"sc-d08486b0-3 byoTNg\" data-cy-id=\"article-content\"><ul> <li>National Australia Bank reported first-quarter FY2026 net interest income of A$4,600 million and net income of A$2,000 million, while also confirming upcoming leadership changes including the phased retirement of long-serving executive Shaun Dooley and the March 2, 2026 commencement of incoming Group Chief Financial Officer and Group Executive Strategy, Inder Singh.</li> <li>Alongside the earnings update, NAB is reshaping its leadership and physical footprint, combining executive transitions with a A$109 million program to modernise 170 branches and launch integrated financial centres and Community Hubs that concentrate multiple banking services in single locations.</li> <li>We‚Äôll now explore how NAB‚Äôs strong quarterly profit and the incoming CFO‚Äôs appointment might influence the bank‚Äôs longer-term investment narrative.</li> </ul><p>Capitalize on the AI infrastructure supercycle with our selection of the <a class=\"company-report-links\" data-vars-link-type=\"intro\" href=\"https://simplywall.st/discover/investing-ideas/473744/ai-infrastructure-stocks/global\" rel=\"noopener noreferrer\" target=\"_blank\">33 best 'picks and shovels' of the AI gold rush</a> converting record-breaking demand into massive cash flow.</p><div class=\"relative grid grid-rows-[25px_auto] place-items-center bg-surface @container/article-body-ad [[data-brand='v2']_&amp;]:bg-surface-1\" data-cy-id=\"article-body-ad\"><div class=\"text-tiny text-softer\">Advertisement</div><div class=\"relative h-[250px] min-h-[250px] w-[300px] min-w-[300px] @[380px]/article-body-ad:h-[280px] @[380px]/article-body-ad:min-h-[280px] @[380px]/article-body-ad:w-[336px] @[380px]/article-body-ad:min-w-[336px]\"><div data-fuse=\"news_incontent_1\" id=\"news_incontent_1\"></div></div></div><h2>National Australia Bank Investment Narrative Recap</h2><p>To own NAB, you need to believe it can convert its strong Australian franchise and ongoing digital investment into steady profits while managing credit and cost risks. The latest quarter‚Äôs A$4,600 million net interest income and A$2,000 million net income support that thesis, but they do not materially change the near term focus on execution in business lending and disciplined cost control, or the key risk around rising competition from digital players and fintechs.</p> <p>The most relevant update here is NAB‚Äôs A$109 million plan to modernise 170 branches and roll out integrated financial centres and Community Hubs. For investors watching digital disruption and cost pressure, this bricks and mortar upgrade sits alongside NAB‚Äôs broader technology and productivity push, and may influence how you think about the balance between physical presence, digital channels and the cost-to-income trajectory as a catalyst for the stock.</p> <p>Yet beneath the solid quarter, investors should be aware that rising compliance, technology and branch investment costs could still...</p> <p><a class=\"company-report-links\" data-vars-link-type=\"integrated-pitch\" href=\"https://simplywall.st/community/narratives/au/banks/asx-nab/national-australia-bank-shares/2uq42vtb-digital-payments-and-urban-expansion-will-unlock-opportunities-hd4o\" rel=\"noopener noreferrer\" target=\"_blank\">Read the full narrative on National Australia Bank (it's free!)</a></p><p>National Australia Bank's narrative projects A$22.7 billion revenue and A$7.3 billion earnings by 2028. This requires 4.2% yearly revenue growth and about A$0.3 billion earnings increase from A$7.0 billion today.</p><p><a class=\"company-report-links\" data-vars-link-type=\"integrated-pitch\" href=\"https://simplywall.st/community/narratives/au/banks/asx-nab/national-australia-bank-shares/2uq42vtb-digital-payments-and-urban-expansion-will-unlock-opportunities-hd4o\" rel=\"noopener noreferrer\" target=\"_blank\">Uncover how National Australia Bank's forecasts yield a A$39.23 fair value</a>, a 20% downside to its current price.</p><h2>Exploring Other Perspectives</h2><figure><a class=\"company-report-links\" data-vars-link-type=\"infographic\" href=\"https://simplywall.st/stocks/au/banks/asx-nab/national-australia-bank-shares\" rel=\"noopener noreferrer\" target=\"_blank\"><img alt=\"ASX:NAB 1-Year Stock Price Chart\" class=\"sc-3204b94-0 iJdSPa\" height=\"476\" loading=\"lazy\" src=\"https://images.simplywall.st/company/e2abe6a2-4b26-498a-b7b6-fe5dff147c8a/chart/quote-price\" width=\"746\"/></a><figcaption>ASX:NAB 1-Year Stock Price Chart</figcaption></figure> <p>Before this news, the most optimistic analysts were banking on revenue of about A$24.7 billion and A$8.4 billion in earnings by 2028, which is a more upbeat story than consensus. If you compare that to the risk that faster digitisation could squeeze NAB‚Äôs margins, you can see how views can diverge sharply and why this latest update might reshape how you weigh those upside and downside cases.</p><p><a class=\"company-report-links\" data-vars-link-type=\"integrated-pitch\" href=\"https://simplywall.st/community/narratives/au/banks/asx-nab/national-australia-bank-shares\" rel=\"noopener noreferrer\" target=\"_blank\">Explore 6 other fair value estimates on National Australia Bank</a> - why the stock might be worth 39% less than the current price!</p><h2>Reach Your Own Conclusion</h2><p>Don't just follow the ticker - dig into the data and build a conviction that's truly your own.</p><ul><li>A great starting point for your National Australia Bank research is our analysis highlighting <a class=\"company-report-links\" data-vars-link-type=\"conclusion\" href=\"https://simplywall.st/stocks/au/banks/asx-nab/national-australia-bank-shares\" rel=\"noopener noreferrer\" target=\"_blank\">2 key rewards and 2 important warning signs</a> that could impact your investment decision.</li><li><a class=\"company-report-links\" data-vars-link-type=\"conclusion\" href=\"https://simplywall.st/stocks/au/banks/asx-nab/national-australia-bank-shares\" rel=\"noopener noreferrer\" target=\"_blank\">Our free National Australia Bank research report</a> provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate National Australia Bank's overall financial health at a glance.</li></ul><h2>Seeking Other Investments?</h2><p>Our top stock finds are flying under the radar-for now. Get in early:</p><ul><li>Invest in the nuclear renaissance through our list of <a class=\"company-report-links\" data-vars-link-type=\"conclusion-grid\" href=\"https://simplywall.st/discover/investing-ideas/473644/nuclear-renaissance/global\" rel=\"noopener noreferrer\" target=\"_blank\">84 elite nuclear energy infrastructure plays</a> powering the global AI revolution.</li><li>We've uncovered the <a class=\"company-report-links\" data-vars-link-type=\"conclusion-grid\" href=\"https://simplywall.st/discover/investing-ideas/473528/dividend-fortresses/au\" rel=\"noopener noreferrer\" target=\"_blank\">9 dividend fortresses</a> yielding 5%+ that don't just survive market storms, but thrive in them.</li><li>Uncover the next big thing with <a class=\"company-report-links\" data-vars-link-type=\"conclusion-grid\" href=\"https://simplywall.st/discover/investing-ideas/472945/elite-penny-stocks/au\" rel=\"noopener noreferrer\" target=\"_blank\">60 elite penny stocks</a> that balance risk and reward.</li></ul> <p><em> This article by Simply Wall St is general in nature. <strong>We provide commentary based on historical data\n    and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice.</strong> It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your\n    financial situation. We aim to bring you long-term focused analysis driven by fundamental data.\n    Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material.\n    Simply Wall St has no position in any stocks mentioned.</em></p><div class=\"sc-80c0fb9d-0 hLZAWP\"><h3 class=\"m-0 text-balance text-mega font-medium mb-4 font-serif\">Valuation is complex, but we're here to simplify it.</h3><p>Discover if National Australia Bank might be undervalued or overvalued with our detailed analysis, featuring <strong>fair value estimates, potential risks, dividends, insider trades, and its financial condition.</strong></p><a class=\"sc-kuACkN kjLJKA !text-[--s-button-primary-color-text] !no-underline\" data-focus=\"dashed\" href=\"/stocks/au/banks/asx-nab/national-australia-bank-shares/valuation\" target=\"_blank\">Access Free Analysis</a></div></div>",
            "pub_date": "2026-02-26 20:10:47",
            "link": "https://simplywall.st/stocks/au/banks/asx-nab/national-australia-bank-shares/news/is-nabs-strong-q1-profit-and-new-cfo-shaping-a-different-lon",
            "source": "simplywall",
            "kind": 1,
            "language": "en"
        },
        {
            "title": "Eastman Chemical Results Highlight Cash Strength Recycling Progress And Dividend Questions",
            "description": "<div class=\"sc-d08486b0-3 byoTNg\" data-cy-id=\"article-content\"><ul> <li>Eastman Chemical (NYSE:EMN) released its full year 2025 results, emphasizing strong cash generation.</li> <li>The company reported that it exceeded its cost reduction targets for the year.</li> <li>Management also highlighted progress at the Kingsport methanolysis plant, where recycling efforts advanced further.</li> </ul> <p>Eastman Chemical, a global specialty materials producer, continues to focus on cash generation and cost discipline while operating in a mixed economic backdrop. For investors, the latest update on the Kingsport methanolysis plant matters because it ties Eastman's core plastics and chemicals businesses to circular recycling efforts that many brands and regulators are watching closely.</p> <p>Looking ahead, the combination of cash generation, ongoing cost control, and visible progress on recycling may keep NYSE:EMN on the radar for investors who care about both income and sustainability. The company‚Äôs history of dividend payments, together with its recycling initiatives, provides a couple of clear themes to track in future annual updates.</p> <p>Stay updated on the most important news stories for <a class=\"company-report-links\" data-vars-link-type=\"news_stay_updated_cta\" href=\"https://www.simplywall.st/stocks/us/materials/nyse-emn/eastman-chemical/valuation\" rel=\"noopener noreferrer\" target=\"_blank\">Eastman Chemical</a> by adding it to your <a class=\"company-report-links\" data-vars-link-type=\"news_stay_updated_cta\" href=\"https://simplywall.st/features/stock-watchlist\" rel=\"noopener noreferrer\" target=\"_blank\">watchlist</a> or <a class=\"company-report-links\" data-vars-link-type=\"news_stay_updated_cta\" href=\"https://simplywall.st/features/portfolio\" rel=\"noopener noreferrer\" target=\"_blank\">portfolio</a>. Alternatively, explore our <a class=\"company-report-links\" data-vars-link-type=\"news_stay_updated_cta\" href=\"https://simplywall.st/stock/NYSE/EMN\" rel=\"noopener noreferrer\" target=\"_blank\">Community</a> to discover new perspectives on Eastman Chemical.</p> <figure><a class=\"company-report-links\" data-vars-link-type=\"infographic\" href=\"https://www.simplywall.st/stocks/us/materials/nyse-emn/eastman-chemical/future\" rel=\"noopener noreferrer\" target=\"_blank\"><img alt=\"NYSE:EMN Earnings &amp; Revenue Growth as at Feb 2026\" class=\"sc-3204b94-0 iJdSPa\" height=\"476\" loading=\"lazy\" src=\"https://images.simplywall.st/company/a377fb20-09b3-4fd6-8995-50cc29d323e0/chart/earnings-and-revenue-growth?date=2026-02-26\" width=\"746\"/></a><figcaption>NYSE:EMN Earnings &amp; Revenue Growth as at Feb 2026</figcaption></figure> <p><a class=\"company-report-links\" data-vars-link-type=\"cta_news_dividend\" href=\"https://www.simplywall.st/stocks/us/materials/nyse-emn/eastman-chemical/dividend\" rel=\"noopener noreferrer\" target=\"_blank\">Is Eastman Chemical's dividend sustainable? Check out what every dividend investor needs to know in our dividend analysis.</a></p> <p>For dividend-focused investors, Eastman Chemical‚Äôs full year update links directly to how dependable its cash returns might be. The company highlighted strong cash generation and again affirmed a quarterly dividend of $0.84 per share, which continues a multi year pattern of regular payments. At the same time, Simply Wall St‚Äôs risk checks point out that the dividend is not well covered by free cash flow and that debt is not well covered by operating cash flow. The recent issue of US$600m in 4.50% senior unsecured notes due 2031 adds another fixed claim on future cash. Together, those details suggest you may want to look closely at payout ratios, interest costs, and how much cash is left for reinvestment after dividends and debt service.</p> <div class=\"relative grid grid-rows-[25px_auto] place-items-center bg-surface @container/article-body-ad [[data-brand='v2']_&amp;]:bg-surface-1\" data-cy-id=\"article-body-ad\"><div class=\"text-tiny text-softer\">Advertisement</div><div class=\"relative h-[250px] min-h-[250px] w-[300px] min-w-[300px] @[380px]/article-body-ad:h-[280px] @[380px]/article-body-ad:min-h-[280px] @[380px]/article-body-ad:w-[336px] @[380px]/article-body-ad:min-w-[336px]\"><div data-fuse=\"news_incontent_1\" id=\"news_incontent_1\"></div></div></div><h3>How This Fits Into The Eastman Chemical Narrative</h3> <ul> <li>The focus on cost reduction, cash generation, and expanding molecular recycling at Kingsport supports the narrative that efficiency and asset utilization can help free up cash to fund both growth projects and dividends.</li> <li>The additional debt and flagged concerns about cash flow coverage could challenge the idea that cost savings alone will keep returns to shareholders comfortable if end market demand stays weak.</li> <li>The fixed income issuance and detailed recycling ramp at Kingsport add extra color on capital structure and sustainability execution that is not fully captured in the high level narrative.</li> </ul> <p>Knowing what a company is worth starts with understanding its story.\n<a class=\"company-report-links\" data-vars-link-type=\"integrated-pitch\" href=\"https://simplywall.st/narratives/ujv3juw5-commodity-end-markets-and-recycling-initiatives-will-shape-recovery-prospects-ahead\" rel=\"noopener noreferrer\" target=\"_blank\">Check out one of the top narratives in the Simply Wall St Community for Eastman Chemical</a> to help decide what it is worth to you.</p> <h3>The Risks and Rewards Investors Should Consider</h3> <ul> <li>‚ö†Ô∏è Profit margins are lower than last year and debt is not well covered by operating cash flow, which could limit room for dividend growth if trading conditions stay soft.</li> <li>‚ö†Ô∏è The dividend is not well covered by free cash flows, so a higher cash commitment to interest on the new 4.50% notes may tighten headroom for future payouts.</li> <li>üéÅ Eastman is trading at a discount to one fair value estimate and is viewed as good value compared to peers such as Dow and LyondellBasell, which can be appealing for income investors willing to accept some risk.</li> <li>üéÅ Earnings are forecast to grow, and cost savings plus Kingsport recycling progress support the idea that free cash flow could improve over time if execution stays on track.</li> </ul> <h3>What To Watch Going Forward</h3> <p>From here, it makes sense to watch three things if you follow Eastman Chemical for income. First, how free cash flow tracks against the dividend and interest costs on the new US$600m notes. Second, whether margins begin to recover toward prior levels, which would give more support to the payout. Third, progress at Kingsport in converting recycling volumes into consistent earnings and cash. Together, these will help you judge how resilient the dividend really is through the rest of the cycle.</p> <p>To stay up to date on how the latest news impacts the investment narrative for Eastman Chemical, head to the\n<a class=\"company-report-links\" href=\"https://www.simplywall.st/stock/NYSE/EMN\" rel=\"noopener noreferrer\" target=\"_blank\">community page for Eastman Chemical</a> to follow the top community narratives.</p> <p><em> This article by Simply Wall St is general in nature. <strong>We provide commentary based on historical data\n    and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice.</strong> It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your\n    financial situation. We aim to bring you long-term focused analysis driven by fundamental data.\n    Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material.\n    Simply Wall St has no position in any stocks mentioned.</em></p><div class=\"sc-80c0fb9d-0 hLZAWP\"><h3 class=\"m-0 text-balance text-mega font-medium mb-4 font-serif\">Valuation is complex, but we're here to simplify it.</h3><p>Discover if Eastman Chemical might be undervalued or overvalued with our detailed analysis, featuring <strong>fair value estimates, potential risks, dividends, insider trades, and its financial condition.</strong></p><a class=\"sc-kuACkN kjLJKA !text-[--s-button-primary-color-text] !no-underline\" data-focus=\"dashed\" href=\"/stocks/us/materials/nyse-emn/eastman-chemical/valuation\" target=\"_blank\">Access Free Analysis</a></div></div>",
            "pub_date": "2026-02-26 20:10:47",
            "link": "https://simplywall.st/stocks/us/materials/nyse-emn/eastman-chemical/news/eastman-chemical-results-highlight-cash-strength-recycling-p",
            "source": "simplywall",
            "kind": 1,
            "language": "en"
        },
        {
            "title": "Vistra Bets On Gas And Nuclear To Power Data Center Demand",
            "description": "<div class=\"sc-d08486b0-3 byoTNg\" data-cy-id=\"article-content\"><ul> <li>Vistra (NYSE:VST) has committed around $4 billion to acquire natural gas and nuclear power plants, targeting rising electricity needs from data centers.</li> <li>The company reports significant growth in EBITDA and dividends alongside this expansion in generation assets.</li> <li>These moves mark a shift in Vistra's business mix toward serving large, power intensive customers such as data centers.</li> </ul> <p>Vistra, a major US power producer and retailer, is leaning into the surge in electricity demand tied to data center build outs. By adding natural gas and nuclear capacity, NYSE:VST is increasing its exposure to dispatchable power that can serve round the clock loads. For investors, the mix of large asset purchases and higher dividends puts both capital allocation and balance sheet decisions in focus.</p> <p>The company is positioning itself to be a key supplier to data centers that require reliable, large scale power. The combination of new generation assets and a growing dividend stream gives investors several angles to watch, from cash flow stability to how effectively Vistra integrates and operates its expanded fleet.</p> <p>Stay updated on the most important news stories for <a class=\"company-report-links\" data-vars-link-type=\"news_stay_updated_cta\" href=\"https://www.simplywall.st/stocks/us/utilities/nyse-vst/vistra/valuation\" rel=\"noopener noreferrer\" target=\"_blank\">Vistra</a> by adding it to your <a class=\"company-report-links\" data-vars-link-type=\"news_stay_updated_cta\" href=\"https://simplywall.st/features/stock-watchlist\" rel=\"noopener noreferrer\" target=\"_blank\">watchlist</a> or <a class=\"company-report-links\" data-vars-link-type=\"news_stay_updated_cta\" href=\"https://simplywall.st/features/portfolio\" rel=\"noopener noreferrer\" target=\"_blank\">portfolio</a>. Alternatively, explore our <a class=\"company-report-links\" data-vars-link-type=\"news_stay_updated_cta\" href=\"https://simplywall.st/stock/NYSE/VST\" rel=\"noopener noreferrer\" target=\"_blank\">Community</a> to discover new perspectives on Vistra.</p> <figure><a class=\"company-report-links\" data-vars-link-type=\"infographic\" href=\"https://www.simplywall.st/stocks/us/utilities/nyse-vst/vistra/future\" rel=\"noopener noreferrer\" target=\"_blank\"><img alt=\"NYSE:VST Earnings &amp; Revenue Growth as at Feb 2026\" class=\"sc-3204b94-0 iJdSPa\" height=\"476\" loading=\"lazy\" src=\"https://images.simplywall.st/company/539c60ee-bc50-4342-b6fb-5cde1db88e90/chart/earnings-and-revenue-growth?date=2026-02-26\" width=\"746\"/></a><figcaption>NYSE:VST Earnings &amp; Revenue Growth as at Feb 2026</figcaption></figure> <p><a class=\"company-report-links\" data-vars-link-type=\"cta_news_hidden_strengths\" href=\"https://www.simplywall.st/stocks/us/utilities/nyse-vst/vistra\" rel=\"noopener noreferrer\" target=\"_blank\">2 things going right for Vistra that this headline doesn't cover.</a></p> <p>For Vistra, committing around US$4b to natural gas and nuclear assets is a clear push toward long term, contract backed cash flows from power intensive customers such as data centers. These plants can run consistently, which lines up with the 24/7 needs of hyperscalers and large corporates. The reported 13.9% growth in adjusted EBITDA over the first nine months of 2025 sits alongside a dividend profile that includes a common dividend with a five year compound annual growth rate of 10.7% and a preferred Series A payout of US$80.00 per share on an annualized basis. That combination suggests management is comfortable returning more cash to shareholders while still writing large checks for acquisitions. For you as an investor, the key question is whether the earnings base from these acquired assets and power contracts can comfortably service higher interest costs, ongoing capital spending, and both common and preferred dividends over time.</p> <div class=\"relative grid grid-rows-[25px_auto] place-items-center bg-surface @container/article-body-ad [[data-brand='v2']_&amp;]:bg-surface-1\" data-cy-id=\"article-body-ad\"><div class=\"text-tiny text-softer\">Advertisement</div><div class=\"relative h-[250px] min-h-[250px] w-[300px] min-w-[300px] @[380px]/article-body-ad:h-[280px] @[380px]/article-body-ad:min-h-[280px] @[380px]/article-body-ad:w-[336px] @[380px]/article-body-ad:min-w-[336px]\"><div data-fuse=\"news_incontent_1\" id=\"news_incontent_1\"></div></div></div><h3>How This Fits Into The Vistra Narrative</h3> <ul> <li>The data center driven acquisitions and new power purchase agreements tie directly into the narrative that rising electricity demand and long duration contracts can support revenue growth and EBITDA expansion.</li> <li>Heavier use of acquisitions and fossil fuel assets, plus a higher leverage profile around 3x adjusted EBITDA, echoes the narrative‚Äôs caution that debt and regulatory pressure on gas and nuclear could constrain future margins.</li> <li>The recent step up in common and preferred dividends is not fully reflected in the narrative and adds another layer of capital allocation that could influence how much cash is left for renewables and storage projects.</li> </ul> <p>Knowing what a company is worth starts with understanding its story.\n<a class=\"company-report-links\" data-vars-link-type=\"integrated-pitch\" href=\"https://simplywall.st/narratives/d88nwa9z-vst-accelerating-power-demand-will-drive-new-nuclear-and-gas-asset-expansion\" rel=\"noopener noreferrer\" target=\"_blank\">Check out one of the top narratives in the Simply Wall St Community for Vistra</a> to help decide what it's worth to you.</p> <h3>The Risks and Rewards Investors Should Consider</h3> <ul> <li>‚ö†Ô∏è Interest payments are not well covered by earnings, which could limit financial flexibility if borrowing costs stay high or new projects run over budget.</li> <li>‚ö†Ô∏è Profit margins of 5.6% compared to 11.4% last year indicate pressure on profitability, which may matter if power prices or plant availability move against Vistra.</li> <li>üéÅ Vistra is assessed as trading at a large discount to one estimate of fair value, which some investors may see as providing a margin of safety if the thesis on data center demand plays out.</li> <li>üéÅ Earnings are forecast to grow 24.84% per year, so if acquisitions and long term contracts perform as planned, the current investment and dividend strategy could be supported by a rising earnings base.</li> </ul> <h3>What To Watch Going Forward</h3> <p>From here, you may want to watch how quickly the newly acquired natural gas and nuclear plants are integrated, what returns Vistra reports on that US$4b outlay, and how stable EBITDA looks as more data center contracts come online. Keep an eye on leverage and interest coverage, because more acquisitions or higher dividends could stretch the balance sheet if power markets turn less favorable. It is also useful to track how Vistra positions itself against peers such as Constellation Energy and Cameco linked nuclear interests, especially around securing multi decade data center power agreements. Earnings updates and any changes to dividend policy will give you clues on whether management is prioritizing growth, debt reduction, or cash returns at each stage.</p> <p>To ensure you're always in the loop on how the latest news impacts the investment narrative for Vistra, head to the\n<a class=\"company-report-links\" href=\"https://www.simplywall.st/stock/NYSE/VST\" rel=\"noopener noreferrer\" target=\"_blank\">community page for Vistra</a> to never miss an update on the top community narratives.</p> <p><em> This article by Simply Wall St is general in nature. <strong>We provide commentary based on historical data\n    and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice.</strong> It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your\n    financial situation. We aim to bring you long-term focused analysis driven by fundamental data.\n    Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material.\n    Simply Wall St has no position in any stocks mentioned.</em></p><div class=\"sc-80c0fb9d-0 hLZAWP\"><h3 class=\"m-0 text-balance text-mega font-medium mb-4 font-serif\"><strong>New: </strong>Manage All Your Stock Portfolios in One Place</h3><p>We've created the <strong>ultimate portfolio companion</strong> for stock investors, <strong>and it's free.</strong></p><p>‚Ä¢ Connect an unlimited number of Portfolios and see your total in one currency<br/>‚Ä¢ Be alerted to new Warning Signs or Risks via email or mobile<br/>‚Ä¢ Track the Fair Value of your stocks<br/></p><a class=\"sc-kuACkN kjLJKA !text-[--s-button-primary-color-text] !no-underline\" data-focus=\"dashed\" href=\"https://simplywall.st/features/portfolio\" target=\"_blank\">Try a Demo Portfolio for Free</a></div></div>",
            "pub_date": "2026-02-26 20:10:47",
            "link": "https://simplywall.st/stocks/us/utilities/nyse-vst/vistra/news/vistra-bets-on-gas-and-nuclear-to-power-data-center-demand",
            "source": "simplywall",
            "kind": 1,
            "language": "en"
        },
        {
            "title": "Kering Reweights Brand Portfolio As Gucci Reset Tests Group Resilience",
            "description": "<div class=\"sc-d08486b0-3 byoTNg\" data-cy-id=\"article-content\"><ul> <li>Kering (ENXTPA:KER) is reshaping its brand portfolio as Gucci works through a reset in its positioning and product offering.</li> <li>The group is putting more emphasis on labels such as Saint Laurent and Bottega Veneta while broader luxury demand shows signs of cooling.</li> <li>This shift marks an important phase for Kering as it adjusts to changing consumer patterns in key luxury markets.</li> </ul> <p>Kering, through brands like Gucci, Saint Laurent and Bottega Veneta, is a major player in global luxury fashion and accessories. With Gucci facing a reset, the group is looking more closely at how each house contributes to its overall profile at a time when demand for high end products is less buoyant than in recent years.</p> <p>For you as an investor, the focus now is on how Kering balances Gucci‚Äôs turnaround efforts with the growing visibility of its other brands. The way the group allocates attention and resources across its portfolio could influence its resilience to changes in consumer spending in its core regions.</p> <p>Stay updated on the most important news stories for <a class=\"company-report-links\" data-vars-link-type=\"news_stay_updated_cta\" href=\"https://www.simplywall.st/stocks/fr/consumer-durables/epa-ker/kering-shares/valuation\" rel=\"noopener noreferrer\" target=\"_blank\">Kering</a> by adding it to your <a class=\"company-report-links\" data-vars-link-type=\"news_stay_updated_cta\" href=\"https://simplywall.st/features/stock-watchlist\" rel=\"noopener noreferrer\" target=\"_blank\">watchlist</a> or <a class=\"company-report-links\" data-vars-link-type=\"news_stay_updated_cta\" href=\"https://simplywall.st/features/portfolio\" rel=\"noopener noreferrer\" target=\"_blank\">portfolio</a>. Alternatively, explore our <a class=\"company-report-links\" data-vars-link-type=\"news_stay_updated_cta\" href=\"https://simplywall.st/stock/ENXTPA/KER\" rel=\"noopener noreferrer\" target=\"_blank\">Community</a> to discover new perspectives on Kering.</p> <figure><a class=\"company-report-links\" data-vars-link-type=\"infographic\" href=\"https://www.simplywall.st/stocks/fr/consumer-durables/epa-ker/kering-shares/future\" rel=\"noopener noreferrer\" target=\"_blank\"><img alt=\"ENXTPA:KER Earnings &amp; Revenue Growth as at Feb 2026\" class=\"sc-3204b94-0 iJdSPa\" height=\"476\" loading=\"lazy\" src=\"https://images.simplywall.st/company/3f2063b3-457d-471a-b9ec-f648b0b69f10/chart/earnings-and-revenue-growth?date=2026-02-26\" width=\"746\"/></a><figcaption>ENXTPA:KER Earnings &amp; Revenue Growth as at Feb 2026</figcaption></figure> <p><a class=\"company-report-links\" data-vars-link-type=\"cta_news_hidden_strengths\" href=\"https://www.simplywall.st/stocks/fr/consumer-durables/epa-ker/kering-shares\" rel=\"noopener noreferrer\" target=\"_blank\">1 thing going right for Kering that this headline doesn't cover.</a></p> <p>This brand reset puts Kering‚Äôs business model under the spotlight because so much of its cash generation and market perception has historically been linked to Gucci. As Gucci works through a repositioning, management is effectively asking the rest of the portfolio to carry more weight. For you, the key question is whether houses like Saint Laurent and Bottega Veneta can deepen their identity without diluting group focus or stretching creative and operational resources at a time when luxury demand is less buoyant.</p> <div class=\"relative grid grid-rows-[25px_auto] place-items-center bg-surface @container/article-body-ad [[data-brand='v2']_&amp;]:bg-surface-1\" data-cy-id=\"article-body-ad\"><div class=\"text-tiny text-softer\">Advertisement</div><div class=\"relative h-[250px] min-h-[250px] w-[300px] min-w-[300px] @[380px]/article-body-ad:h-[280px] @[380px]/article-body-ad:min-h-[280px] @[380px]/article-body-ad:w-[336px] @[380px]/article-body-ad:min-w-[336px]\"><div data-fuse=\"news_incontent_1\" id=\"news_incontent_1\"></div></div></div><h3>How This Fits Into The Kering Narrative</h3> <ul> <li>The increased emphasis on multiple houses lines up with the narrative of product refreshes and store optimization. These are aimed at sharpening brand positioning and improving operating leverage over time.</li> <li>Execution risk at Gucci and other brands, already highlighted in the narrative, is reinforced by this reset. More creative shifts and portfolio changes raise the chance that some collections or market bets do not resonate with consumers.</li> <li>The current news focuses on brand mix and positioning, while the narrative also points to factors like tourism trends and secondhand luxury, which may not be fully reflected in how investors interpret this reset.</li> </ul> <p>Knowing what a company is worth starts with understanding its story.\n<a class=\"company-report-links\" data-vars-link-type=\"integrated-pitch\" href=\"https://simplywall.st/narratives/14mdfsvn-ker-beauty-unit-sale-and-licensing-deal-will-shape-future-market-position\" rel=\"noopener noreferrer\" target=\"_blank\"> Check out one of the top narratives in the Simply Wall St Community for Kering</a> to help decide what it's worth to you.</p> <h3>The Risks and Rewards Investors Should Consider</h3> <ul> <li>‚ö†Ô∏è Execution risk around Gucci‚Äôs repositioning and other creative shifts, which could affect demand if new collections do not connect with core and aspirational buyers.</li> <li>‚ö†Ô∏è Analysts have flagged that Kering‚Äôs interest payments are not well covered by earnings. This can limit flexibility if trading conditions stay soft or turn weaker.</li> <li>üéÅ Analysts expect earnings to grow strongly over the coming years. This suggests upside if Kering‚Äôs portfolio reset and cost discipline play out as planned.</li> <li>üéÅ A stronger role for brands like Saint Laurent and Bottega Veneta could reduce reliance on a single label and help Kering compete more evenly with peers such as LVMH and Herm√®s.</li> </ul> <h3>What To Watch Going Forward</h3> <p>From here, it is worth watching how quickly Gucci‚Äôs refreshed positioning shows up in product traction, pricing, and brand heat, especially with US aspirational shoppers. You can also track whether Saint Laurent, Bottega Veneta, and other houses gain more visibility in key regions without eroding Kering‚Äôs overall margin profile. Competitive moves from large groups like LVMH and Richemont on pricing, store openings, and marketing will give extra context for how Kering‚Äôs choices are landing with luxury consumers.</p> <p>To ensure you're always in the loop on how the latest news impacts the investment narrative for Kering, head to the\n<a class=\"company-report-links\" href=\"https://www.simplywall.st/stock/ENXTPA/KER\" rel=\"noopener noreferrer\" target=\"_blank\"> community page for Kering</a> to never miss an update on the top community narratives.</p> <p><em> This article by Simply Wall St is general in nature. <strong>We provide commentary based on historical data\n    and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice.</strong> It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your\n    financial situation. We aim to bring you long-term focused analysis driven by fundamental data.\n    Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material.\n    Simply Wall St has no position in any stocks mentioned.</em></p><div class=\"sc-80c0fb9d-0 hLZAWP\"><h3 class=\"m-0 text-balance text-mega font-medium mb-4 font-serif\">Valuation is complex, but we're here to simplify it.</h3><p>Discover if Kering might be undervalued or overvalued with our detailed analysis, featuring <strong>fair value estimates, potential risks, dividends, insider trades, and its financial condition.</strong></p><a class=\"sc-kuACkN kjLJKA !text-[--s-button-primary-color-text] !no-underline\" data-focus=\"dashed\" href=\"/stocks/fr/consumer-durables/epa-ker/kering-shares/valuation\" target=\"_blank\">Access Free Analysis</a></div></div>",
            "pub_date": "2026-02-26 20:05:56",
            "link": "https://simplywall.st/stocks/fr/consumer-durables/epa-ker/kering-shares/news/kering-reweights-brand-portfolio-as-gucci-reset-tests-group",
            "source": "simplywall",
            "kind": 1,
            "language": "en"
        },
        {
            "title": "Assessing Stanmore Resources (ASX:SMR) Valuation After Net Loss, Record Output And Higher Dividend",
            "description": "<div class=\"sc-d08486b0-3 byoTNg\" data-cy-id=\"article-content\"><p>Stanmore Resources (ASX:SMR) has grabbed investor attention after reporting a 2025 net loss of US$47.2 million, along with record coal output, solid cash flow and an increased fully franked final dividend.</p> <p><a class=\"company-report-links\" data-vars-link-type=\"cta_company_latest_analysis\" href=\"https://www.simplywall.st/stocks/au/materials/asx-smr/stanmore-resources-shares\" rel=\"noopener noreferrer\" target=\"_blank\">See our latest analysis for Stanmore Resources.</a></p> <p>Despite the latest results and dividend news, the share price reaction has been weak in the short term, with a 1 day share price return of a 6.88% decline and a 30 day share price return of a 14.33% decline. However, the 1 year total shareholder return of 12.20% and very large 5 year total shareholder return suggest longer term holders have still seen strong gains. This points to fading near term momentum as the market reassesses earnings risk against production strength and dividends.</p> <p>If coal and resources are on your radar, this could be a handy moment to broaden your view and check out <a class=\"company-report-links\" data-vars-link-type=\"cta_screener_gold\" href=\"https://simplywall.st/discover/investing-ideas/473651/elite-gold-stocks/global\" rel=\"noopener noreferrer\" target=\"_blank\">26 elite gold producer stocks</a> as another way to source ideas in the commodities space.</p> <p>With Stanmore Resources now trading at A$2.57, a 1 year total return of 12.20% and a switch to a US$47.2 million loss alongside record output and higher dividends, is this weakness a potential entry point, or is the market already pricing in future growth?</p> <div class=\"relative grid grid-rows-[25px_auto] place-items-center bg-surface @container/article-body-ad [[data-brand='v2']_&amp;]:bg-surface-1\" data-cy-id=\"article-body-ad\"><div class=\"text-tiny text-softer\">Advertisement</div><div class=\"relative h-[250px] min-h-[250px] w-[300px] min-w-[300px] @[380px]/article-body-ad:h-[280px] @[380px]/article-body-ad:min-h-[280px] @[380px]/article-body-ad:w-[336px] @[380px]/article-body-ad:min-w-[336px]\"><div data-fuse=\"news_incontent_1\" id=\"news_incontent_1\"></div></div></div><h2>Most Popular Narrative: 19.7% Undervalued</h2> <p>At A$2.57, Stanmore Resources sits below the most followed fair value estimate of A$3.20, which is built on detailed revenue, margin and earnings assumptions.</p> <blockquote> <p><em>The expectation of robust, long-term growth in Indian steel demand, driven by urbanization and infrastructure expansion, is set to boost seaborne demand for Australian metallurgical coal. This positions Stanmore to benefit from sustained volume growth and underpins future revenue expansion.  </em></p> <p><em>Planned brownfield and organic growth projects like the Isaac Downs Extension and Eagle Downs provide visible, low-capex pathways for increasing output and replacing depleting assets, supporting long-term production and revenue resilience.</em></p> </blockquote> <p><em><a class=\"company-report-links\" data-vars-link-type=\"cta_narrative_prompt_after_quote\" href=\"https://www.simplywall.st/narratives/6tyv7dqw-indian-urbanization-and-low-capex-projects-will-boost-seaborne-coal-demand-ksp1\" rel=\"noopener noreferrer\" target=\"_blank\">Read the complete narrative.</a></em></p> <p>Want to see what sits behind that A$3.20 figure? The narrative leans heavily on projected earnings growth, future margins and a richer P/E multiple than the sector.</p> <p>Analysts in this narrative apply an 8.63% discount rate to future cash flows and earnings, assume a gentle revenue drift, and still land on a higher earnings base than today. They also build in a future profit multiple that is well above typical metals and mining levels, implying the market would need to pay up for Stanmore Resources if these assumptions hold.</p> <p>Put simply, this most popular view sees today‚Äôs share price as leaving a gap to fair value, but that gap depends on those revenue, margin and multiple assumptions playing out over time.</p> <p><strong>Result: Fair Value of A$3.20 (UNDERVALUED)</strong></p> <p><a class=\"company-report-links\" data-vars-link-type=\"cta_ai_narrative\" href=\"https://www.simplywall.st/narratives/6tyv7dqw-indian-urbanization-and-low-capex-projects-will-boost-seaborne-coal-demand-ksp1\" rel=\"noopener noreferrer\" target=\"_blank\">Have a read of the narrative in full and understand what's behind the forecasts.</a></p> <p>However, this depends on coal prices and regulatory approvals. Weaker metallurgical coal demand or delays to projects like Isaac Downs could quickly challenge those upbeat assumptions.</p> <p><a class=\"company-report-links\" data-vars-link-type=\"risks_narrative_cta\" href=\"https://www.simplywall.st/stocks/au/materials/asx-smr/stanmore-resources-shares\" rel=\"noopener noreferrer\" target=\"_blank\">Find out about the key risks to this Stanmore Resources narrative.</a></p> <h2>Next Steps</h2> <p>Curious whether the cautious tone here matches your own view of Stanmore Resources? Take a moment to weigh the upside against the risks and form your own stance, then look at the full balance of <a class=\"company-report-links\" data-vars-link-type=\"cta_risks_rewards_analysis\" href=\"https://www.simplywall.st/stocks/au/materials/asx-smr/stanmore-resources-shares\" rel=\"noopener noreferrer\" target=\"_blank\">4 key rewards and 1 important warning sign</a>.</p> <h2>Looking for more investment ideas?</h2> <p>If you are serious about sharpening your portfolio, do not stop at one coal producer. Put a few fresh ideas through your own filter while the market is still reacting.</p> <ul> <li>Target dependable income streams by scanning companies that appear in our <a class=\"company-report-links\" data-vars-link-type=\"cta_screener_dividend\" href=\"https://simplywall.st/discover/investing-ideas/473528/dividend-fortresses/au\" rel=\"noopener noreferrer\" target=\"_blank\">9 dividend fortresses</a> and see which payouts look most consistent with your approach.</li> <li>Hunt for quality at a price that works for you by checking the <a class=\"company-report-links\" data-vars-link-type=\"cta_screener_undervalued\" href=\"https://simplywall.st/discover/investing-ideas/473076/high-quality-undervalued-stocks/au\" rel=\"noopener noreferrer\" target=\"_blank\">8 high quality undervalued stocks</a> and spotting names that merit deeper research.</li> <li>Prioritise capital preservation by reviewing the <a class=\"company-report-links\" data-vars-link-type=\"cta_screener_low_risk\" href=\"https://simplywall.st/discover/investing-ideas/473631/low-risk-leaders/au\" rel=\"noopener noreferrer\" target=\"_blank\">7 resilient stocks with low risk scores</a> and keep a shortlist of businesses that may better fit your comfort with volatility.</li> </ul> <p><em> This article by Simply Wall St is general in nature. <strong>We provide commentary based on historical data\n    and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice.</strong> It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your\n    financial situation. We aim to bring you long-term focused analysis driven by fundamental data.\n    Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material.\n    Simply Wall St has no position in any stocks mentioned.</em></p><div class=\"sc-80c0fb9d-0 hLZAWP\"><h3 class=\"m-0 text-balance text-mega font-medium mb-4 font-serif\"><strong>New: </strong>Manage All Your Stock Portfolios in One Place</h3><p>We've created the <strong>ultimate portfolio companion</strong> for stock investors, <strong>and it's free.</strong></p><p>‚Ä¢ Connect an unlimited number of Portfolios and see your total in one currency<br/>‚Ä¢ Be alerted to new Warning Signs or Risks via email or mobile<br/>‚Ä¢ Track the Fair Value of your stocks<br/></p><a class=\"sc-kuACkN kjLJKA !text-[--s-button-primary-color-text] !no-underline\" data-focus=\"dashed\" href=\"https://simplywall.st/features/portfolio\" target=\"_blank\">Try a Demo Portfolio for Free</a></div></div>",
            "pub_date": "2026-02-26 20:05:56",
            "link": "https://simplywall.st/stocks/au/materials/asx-smr/stanmore-resources-shares/news/assessing-stanmore-resources-asxsmr-valuation-after-net-loss",
            "source": "simplywall",
            "kind": 1,
            "language": "en"
        },
        {
            "title": "Is It Too Late To Consider Ubiquiti (UI) After Its 123% One Year Surge?",
            "description": "<div class=\"sc-d08486b0-3 byoTNg\" data-cy-id=\"article-content\"><ul> <li>If you are wondering whether Ubiquiti's current share price reflects its true worth, this article walks through the key numbers so you can judge the value story for yourself.</li> <li>Ubiquiti's share price recently closed at US$755.43, with returns of 6.8% over 7 days, 37.6% over 30 days, 33.4% year to date, 123.4% over 1 year, 192.3% over 3 years, and 143.0% over 5 years. These figures raise fair questions about what is already priced in and how risk is being viewed.</li> <li>Recent coverage of Ubiquiti has focused on its role in networking and wireless equipment markets, as investors look for companies with established product ecosystems and recognizable brands. This context helps frame why the stock has attracted attention alongside its recent price performance.</li> <li>On our valuation checks Ubiquiti scores 1 out of 6, indicating it appears undervalued on only one of the six metrics we use. You can see the breakdown in this <a class=\"company-report-links\" href=\"https://www.simplywall.st/stocks/us/tech/nyse-ui/ubiquiti/valuation\" rel=\"noopener noreferrer\" target=\"_blank\">valuation score</a>. Next, we will compare several common valuation approaches before finishing with a framework that can help you interpret these results in a more complete way.</li> </ul> <p>Ubiquiti scores just 1/6 on our valuation checks. See what other red flags we found in the <a class=\"company-report-links\" data-vars-link-type=\"cta_low_value_score\" href=\"https://www.simplywall.st/stocks/us/tech/nyse-ui/ubiquiti/valuation\" rel=\"noopener noreferrer\" target=\"_blank\">full valuation breakdown</a>.</p> <div class=\"relative grid grid-rows-[25px_auto] place-items-center bg-surface @container/article-body-ad [[data-brand='v2']_&amp;]:bg-surface-1\" data-cy-id=\"article-body-ad\"><div class=\"text-tiny text-softer\">Advertisement</div><div class=\"relative h-[250px] min-h-[250px] w-[300px] min-w-[300px] @[380px]/article-body-ad:h-[280px] @[380px]/article-body-ad:min-h-[280px] @[380px]/article-body-ad:w-[336px] @[380px]/article-body-ad:min-w-[336px]\"><div data-fuse=\"news_incontent_1\" id=\"news_incontent_1\"></div></div></div><h3>Approach 1: Ubiquiti Discounted Cash Flow (DCF) Analysis</h3> <p>A Discounted Cash Flow, or DCF, model estimates what a company might be worth today by projecting future cash flows and then discounting those back into present value using a required return.</p> <p>For Ubiquiti, the model used is a 2 Stage Free Cash Flow to Equity approach. The latest twelve months Free Cash Flow is reported at about US$699 million. Simply Wall St then extends this with cash flow projections out to 2035, starting with an estimate of US$663.2 million in 2026 and US$743.3 million in 2035, with intermediate years in between. Analysts typically provide forecasts for up to five years, so the later years are extrapolated from earlier trends.</p> <p>When all those projected cash flows are discounted back to today, the DCF model produces an estimated intrinsic value of US$197.14 per share. With the recent share price at US$755.43, this particular model implies the stock is very expensive relative to its cash flow estimate, with an intrinsic discount indicating it is about 283.2% above the DCF value.</p> <p><strong>Result: OVERVALUED</strong></p> <p>Our Discounted Cash Flow (DCF) analysis suggests Ubiquiti may be overvalued by 283.2%. <a class=\"company-report-links\" data-vars-link-type=\"cta_dcf_overvalued\" href=\"https://simplywall.st/discover/investing-ideas/473076/high-quality-undervalued-stocks/us\" rel=\"noopener noreferrer\" target=\"_blank\">Discover 53 high quality undervalued stocks</a> or <a class=\"company-report-links\" data-vars-link-type=\"cta_dcf_overvalued\" href=\"https://simplywall.st/features/stock-screener\" rel=\"noopener noreferrer\" target=\"_blank\">create your own screener</a> to find better value opportunities.</p> <figure><a class=\"company-report-links\" data-vars-link-type=\"infographic\" href=\"https://www.simplywall.st//stocks/us/tech/nyse-ui/ubiquiti/valuation\" rel=\"noopener noreferrer\" target=\"_blank\"><img alt=\"UI Discounted Cash Flow as at Feb 2026\" class=\"sc-3204b94-0 iJdSPa\" height=\"476\" loading=\"lazy\" src=\"https://images.simplywall.st/company/5e5f0b68-c0ff-4b56-8656-fae28f721586/chart/dcf?date=2026-02-26\" width=\"746\"/></a><figcaption>UI Discounted Cash Flow as at Feb 2026</figcaption></figure> <p><a class=\"company-report-links\" data-vars-link-type=\"dcf_explainer_cta\" href=\"https://www.simplywall.st/stocks/us/tech/nyse-ui/ubiquiti/valuation\" rel=\"noopener noreferrer\" target=\"_blank\">Head to the Valuation section of our Company Report for more details on how we arrive at this Fair Value for Ubiquiti.</a></p> <h3>Approach 2: Ubiquiti Price vs Earnings</h3> <p>For a profitable company like Ubiquiti, the P/E ratio is a useful way to think about value because it links what you are paying directly to the earnings the business is currently generating.</p> <p>What counts as a normal or fair P/E depends on how the market views the company‚Äôs growth potential and risk. Higher expected growth or lower perceived risk can support a higher P/E, while slower growth or higher risk usually justifies a lower one.</p> <p>Ubiquiti currently trades on a P/E of 51.45x. That sits above the Communications industry average P/E of about 40.47x, yet below the peer group average of 77.85x. To refine this further, Simply Wall St uses a proprietary ‚ÄúFair Ratio‚Äù of 36.24x for Ubiquiti, which is an estimate of the P/E that would fit its specific earnings growth profile, industry, profit margins, market cap and risk characteristics.</p> <p>This Fair Ratio is more tailored than a simple peer or industry comparison because it adjusts for company specific qualities instead of assuming that all businesses in a sector should trade at similar multiples.</p> <p>Comparing Ubiquiti‚Äôs actual P/E of 51.45x with the Fair Ratio of 36.24x suggests the shares are pricing in more optimism than the model supports.</p> <p><strong>Result: OVERVALUED</strong></p> <figure><a class=\"company-report-links\" data-vars-link-type=\"infographic\" href=\"https://www.simplywall.st//stocks/us/tech/nyse-ui/ubiquiti/valuation\" rel=\"noopener noreferrer\" target=\"_blank\"><img alt=\"NYSE:UI P/E Ratio as at Feb 2026\" class=\"sc-3204b94-0 iJdSPa\" height=\"476\" loading=\"lazy\" src=\"https://images.simplywall.st/company/5e5f0b68-c0ff-4b56-8656-fae28f721586/chart/pe-multiple-vs-industry?date=2026-02-26\" width=\"746\"/></a><figcaption>NYSE:UI P/E Ratio as at Feb 2026</figcaption></figure> <p>P/E ratios tell one story, but what if the real opportunity lies elsewhere? <a class=\"company-report-links\" data-vars-link-type=\"cta_preferred_multiple_contextual\" href=\"https://simplywall.st/discover/investing-ideas/473625/top-founder-led-companies/us\" rel=\"noopener noreferrer\" target=\"_blank\">Start investing in legacies, not executives. Discover our 21 top founder-led companies</a>.</p> <h3>Upgrade Your Decision Making: Choose your Ubiquiti Narrative</h3> <p>Earlier we mentioned that there is an even better way to understand valuation, so let us introduce you to Narratives, which are simply your own story about a company linked directly to your assumptions for fair value, future revenue, earnings and margins.</p> <p>On Simply Wall St, Narratives live inside the Community page and give you a straightforward way to connect what you believe about Ubiquiti‚Äôs business to a financial forecast and then to a fair value estimate that you can compare with today‚Äôs share price.</p> <p>Because Narratives sit on the platform used by millions of investors, you can see how others frame the same numbers, and the system keeps those Narratives updated when new information such as earnings reports or major news is added, so your fair value view stays current without extra effort.</p> <p>For example, one Ubiquiti Narrative might assume more modest revenue growth and lower long term profit margins, while another might expect stronger growth and higher margins. These different assumptions can lead to very different fair values and therefore very different views on whether the current US$755.43 price looks attractive or stretched.</p> <p>Do you think there's more to the story for Ubiquiti? <a class=\"company-report-links\" data-vars-link-type=\"cta_create_narrative_community\" href=\"https://simplywall.st/stock/NYSE/UI\" rel=\"noopener noreferrer\" target=\"_blank\">Head over to our Community to see what others are saying!</a></p> <figure><a class=\"company-report-links\" data-vars-link-type=\"infographic\" href=\"https://www.simplywall.st//stocks/us/tech/nyse-ui/ubiquiti\" rel=\"noopener noreferrer\" target=\"_blank\"><img alt=\"NYSE:UI 1-Year Stock Price Chart\" class=\"sc-3204b94-0 iJdSPa\" height=\"476\" loading=\"lazy\" src=\"https://images.simplywall.st/company/5e5f0b68-c0ff-4b56-8656-fae28f721586/chart/quote-price?date=2026-02-26\" width=\"746\"/></a><figcaption>NYSE:UI 1-Year Stock Price Chart</figcaption></figure> <p><em> This article by Simply Wall St is general in nature. <strong>We provide commentary based on historical data\n    and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice.</strong> It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your\n    financial situation. We aim to bring you long-term focused analysis driven by fundamental data.\n    Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material.\n    Simply Wall St has no position in any stocks mentioned.</em></p><div class=\"sc-80c0fb9d-0 hLZAWP\"><h3 class=\"m-0 text-balance text-mega font-medium mb-4 font-serif\"><strong>New: </strong>AI Stock Screener &amp; Alerts</h3><p>Our new AI Stock Screener scans the market every day to uncover opportunities.</p><p>‚Ä¢ Dividend Powerhouses (3%+ Yield)<br/>‚Ä¢ Undervalued Small Caps with Insider Buying<br/>‚Ä¢ High growth Tech and AI Companies<br/><br/>Or build your own from over 50 metrics.</p><a class=\"sc-kuACkN kjLJKA !text-[--s-button-primary-color-text] !no-underline\" data-focus=\"dashed\" href=\"https://simplywall.st/features/stock-screener\" target=\"_blank\">Explore Now for Free</a></div></div>",
            "pub_date": "2026-02-26 20:05:56",
            "link": "https://simplywall.st/stocks/us/tech/nyse-ui/ubiquiti/news/is-it-too-late-to-consider-ubiquiti-ui-after-its-123-one-yea",
            "source": "simplywall",
            "kind": 1,
            "language": "en"
        },
        {
            "title": "Is Pulse Biosciences (PLSE) Share Price Justified After Recent Volatility In Healthcare Sentiment",
            "description": "<div class=\"sc-d08486b0-3 byoTNg\" data-cy-id=\"article-content\"><ul> <li>If you are wondering whether Pulse Biosciences at around US$19.21 is priced fairly or if the market is getting ahead of itself, this article walks through what the numbers indicate about its value.</li> <li>The share price has had a mixed run, with a 24.5% decline over the last week, a 34.1% gain over the last month, a 43.5% gain year to date, a 0.7% decline over the last year, a very large 3 year return of around 7x, and a 30.8% decline over five years.</li> <li>Recent news coverage around Pulse Biosciences has focused on its position in the healthcare space and shifting investor expectations. This helps explain why the share price has moved sharply over different time frames. This context matters, because changing sentiment can affect how investors weigh potential future outcomes against the current share price.</li> <li>Right now, our valuation model gives Pulse Biosciences a value score of <a class=\"company-report-links\" href=\"https://www.simplywall.st/stocks/us/healthcare/nasdaq-plse/pulse-biosciences/valuation\" rel=\"noopener noreferrer\" target=\"_blank\">0 out of 6</a>. Next, we will look at how different valuation approaches view the stock, and then finish with a more complete way to think about what that means for you as an investor.</li> </ul> <p>Pulse Biosciences scores just 0/6 on our valuation checks. See what other red flags we found in the <a class=\"company-report-links\" data-vars-link-type=\"cta_low_value_score\" href=\"https://www.simplywall.st/stocks/us/healthcare/nasdaq-plse/pulse-biosciences/valuation\" rel=\"noopener noreferrer\" target=\"_blank\">full valuation breakdown</a>.</p> <div class=\"relative grid grid-rows-[25px_auto] place-items-center bg-surface @container/article-body-ad [[data-brand='v2']_&amp;]:bg-surface-1\" data-cy-id=\"article-body-ad\"><div class=\"text-tiny text-softer\">Advertisement</div><div class=\"relative h-[250px] min-h-[250px] w-[300px] min-w-[300px] @[380px]/article-body-ad:h-[280px] @[380px]/article-body-ad:min-h-[280px] @[380px]/article-body-ad:w-[336px] @[380px]/article-body-ad:min-w-[336px]\"><div data-fuse=\"news_incontent_1\" id=\"news_incontent_1\"></div></div></div><h3>Approach 1: Pulse Biosciences Discounted Cash Flow (DCF) Analysis</h3> <p>A Discounted Cash Flow, or DCF, model takes estimates of a company‚Äôs future cash flows and discounts them back to today using a required rate of return. This process arrives at an estimate of what the business might be worth now.</p> <p>For Pulse Biosciences, the model used is a 2 Stage Free Cash Flow to Equity approach, based on projected free cash flows in dollars. The latest twelve month free cash flow is a loss of about $54.7 million. Analyst and extrapolated estimates in the model show cash flows staying negative in the near term, then turning positive by 2030, with projected free cash flow of $10 million in that year. Further out, the model extends these projections through 2035 using estimated growth rates.</p> <p>After discounting all those projected cash flows, the DCF model arrives at an estimated intrinsic value of about $2.62 per share. Compared with the current share price of around $19.21, this DCF output suggests the stock is very expensive relative to the cash flows assumed in the model, or in other words, very overvalued.</p> <p><strong>Result: OVERVALUED</strong></p> <p>Our Discounted Cash Flow (DCF) analysis suggests Pulse Biosciences may be overvalued by 633.7%. <a class=\"company-report-links\" data-vars-link-type=\"cta_dcf_overvalued\" href=\"https://simplywall.st/discover/investing-ideas/473076/high-quality-undervalued-stocks/us\" rel=\"noopener noreferrer\" target=\"_blank\">Discover 53 high quality undervalued stocks</a> or <a class=\"company-report-links\" data-vars-link-type=\"cta_dcf_overvalued\" href=\"https://simplywall.st/features/stock-screener\" rel=\"noopener noreferrer\" target=\"_blank\">create your own screener</a> to find better value opportunities.</p> <figure><a class=\"company-report-links\" data-vars-link-type=\"infographic\" href=\"https://www.simplywall.st//stocks/us/healthcare/nasdaq-plse/pulse-biosciences/valuation\" rel=\"noopener noreferrer\" target=\"_blank\"><img alt=\"PLSE Discounted Cash Flow as at Feb 2026\" class=\"sc-3204b94-0 iJdSPa\" height=\"476\" loading=\"lazy\" src=\"https://images.simplywall.st/company/7900ed03-6abe-4aba-9042-cb7f3f3204fc/chart/dcf?date=2026-02-26\" width=\"746\"/></a><figcaption>PLSE Discounted Cash Flow as at Feb 2026</figcaption></figure> <p><a class=\"company-report-links\" data-vars-link-type=\"dcf_explainer_cta\" href=\"https://www.simplywall.st/stocks/us/healthcare/nasdaq-plse/pulse-biosciences/valuation\" rel=\"noopener noreferrer\" target=\"_blank\">Head to the Valuation section of our Company Report for more details on how we arrive at this Fair Value for Pulse Biosciences.</a></p> <h3>Approach 2: Pulse Biosciences Price vs Book</h3> <p>For companies that are not yet producing consistent profits, P/B is often more useful than P/E because it compares the share price with the accounting value of net assets rather than earnings that may still be negative or volatile.</p> <p>In general, a higher multiple is easier to justify when investors expect stronger growth and see lower risk, while a lower multiple tends to reflect more modest expectations or higher uncertainty. That is why context matters when you look at any headline ratio.</p> <p>Pulse Biosciences currently trades on a P/B of about 16.19x. This sits above the Medical Equipment industry average P/B of about 2.44x and also above the peer group average of around 3.21x. Simply Wall St also uses a proprietary ‚ÄúFair Ratio‚Äù for the preferred multiple, which estimates what a reasonable P/B might be after considering factors such as earnings growth, profit margins, industry, market cap and specific risks.</p> <p>Because the Fair Ratio is tailored to the company, it can give a more focused view than a simple comparison with industry or peer averages. In this case, the actual 16.19x P/B sits above the Fair Ratio used in the model, which points to the shares trading on a richer multiple than that framework would suggest.</p> <p><strong>Result: OVERVALUED</strong></p> <figure><a class=\"company-report-links\" data-vars-link-type=\"infographic\" href=\"https://www.simplywall.st//stocks/us/healthcare/nasdaq-plse/pulse-biosciences/valuation\" rel=\"noopener noreferrer\" target=\"_blank\"><img alt=\"NasdaqCM:PLSE P/B Ratio as at Feb 2026\" class=\"sc-3204b94-0 iJdSPa\" height=\"476\" loading=\"lazy\" src=\"https://images.simplywall.st/company/7900ed03-6abe-4aba-9042-cb7f3f3204fc/chart/pb-multiple-vs-industry?date=2026-02-26\" width=\"746\"/></a><figcaption>NasdaqCM:PLSE P/B Ratio as at Feb 2026</figcaption></figure> <p>P/B ratios tell one story, but what if the real opportunity lies elsewhere? <a class=\"company-report-links\" data-vars-link-type=\"cta_preferred_multiple_contextual\" href=\"https://simplywall.st/discover/investing-ideas/473625/top-founder-led-companies/us\" rel=\"noopener noreferrer\" target=\"_blank\">Start investing in legacies, not executives. Discover our 21 top founder-led companies</a>.</p> <h3>Upgrade Your Decision Making: Choose your Pulse Biosciences Narrative</h3> <p>Earlier we mentioned that there is an even better way to think about valuation. On Simply Wall St you can use Narratives, where you write your own story for Pulse Biosciences by linking your expectations for revenue, earnings and margins to a forecast, a fair value and a clear comparison of that fair value with today‚Äôs price. This is all within an easy Community tool that millions of investors use, and that automatically updates when new news or earnings arrive. One investor might set a higher fair value around US$30 based on a very optimistic view of thyroid and cardiac adoption, while another might use a lower fair value around US$22 based on more moderate assumptions. You can immediately see how far each view sits from the current price to help you decide what you want to do.</p> <p>Do you think there's more to the story for Pulse Biosciences? <a class=\"company-report-links\" data-vars-link-type=\"cta_create_narrative_community\" href=\"https://simplywall.st/stock/NasdaqCM/PLSE\" rel=\"noopener noreferrer\" target=\"_blank\">Head over to our Community to see what others are saying!</a></p> <figure><a class=\"company-report-links\" data-vars-link-type=\"infographic\" href=\"https://www.simplywall.st//stocks/us/healthcare/nasdaq-plse/pulse-biosciences\" rel=\"noopener noreferrer\" target=\"_blank\"><img alt=\"NasdaqCM:PLSE 1-Year Stock Price Chart\" class=\"sc-3204b94-0 iJdSPa\" height=\"476\" loading=\"lazy\" src=\"https://images.simplywall.st/company/7900ed03-6abe-4aba-9042-cb7f3f3204fc/chart/quote-price?date=2026-02-26\" width=\"746\"/></a><figcaption>NasdaqCM:PLSE 1-Year Stock Price Chart</figcaption></figure> <p><em> This article by Simply Wall St is general in nature. <strong>We provide commentary based on historical data\n    and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice.</strong> It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your\n    financial situation. We aim to bring you long-term focused analysis driven by fundamental data.\n    Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material.\n    Simply Wall St has no position in any stocks mentioned.</em></p><div class=\"sc-80c0fb9d-0 hLZAWP\"><h3 class=\"m-0 text-balance text-mega font-medium mb-4 font-serif\"><strong>New: </strong>Manage All Your Stock Portfolios in One Place</h3><p>We've created the <strong>ultimate portfolio companion</strong> for stock investors, <strong>and it's free.</strong></p><p>‚Ä¢ Connect an unlimited number of Portfolios and see your total in one currency<br/>‚Ä¢ Be alerted to new Warning Signs or Risks via email or mobile<br/>‚Ä¢ Track the Fair Value of your stocks<br/></p><a class=\"sc-kuACkN kjLJKA !text-[--s-button-primary-color-text] !no-underline\" data-focus=\"dashed\" href=\"https://simplywall.st/features/portfolio\" target=\"_blank\">Try a Demo Portfolio for Free</a></div></div>",
            "pub_date": "2026-02-26 20:05:56",
            "link": "https://simplywall.st/stocks/us/healthcare/nasdaq-plse/pulse-biosciences/news/is-pulse-biosciences-plse-share-price-justified-after-recent",
            "source": "simplywall",
            "kind": 1,
            "language": "en"
        },
        {
            "title": "Salesforce Momentum Deal Ties AI Workflows To Depressed Valuation Potential",
            "description": "<div class=\"sc-d08486b0-3 byoTNg\" data-cy-id=\"article-content\"><ul> <li>Salesforce (NYSE:CRM) is acquiring Momentum to bring AI-driven conversational insights and workflow automation into Agentforce 360 and Slack.</li> <li>The deal aims to ingest and analyze unstructured voice and video data from third party channels and feed those insights directly into enterprise sales and service workflows.</li> </ul> <p>Salesforce, trading at $191.75, is leaning further into AI capabilities at a time when its share price has seen mixed performance. The stock is up 2.1% over the past week but has seen a 16.4% decline over 30 days and a 24.4% decline year to date, while the 1 year return stands at a 37.2% decline. In that context, this acquisition highlights how the company is sharpening its AI product roadmap around Agentforce 360 and Slack.</p> <p>For investors, the Momentum deal reflects Salesforce's push to turn AI features into products that can be embedded in everyday workflows and potentially monetized more directly. It also underscores Salesforce's focus on agentic AI platforms that can interpret unstructured customer interactions and surface context aware recommendations for sales and service teams.</p> <p>Stay updated on the most important news stories for <a class=\"company-report-links\" data-vars-link-type=\"news_stay_updated_cta\" href=\"https://www.simplywall.st/stocks/us/software/nyse-crm/salesforce/valuation\" rel=\"noopener noreferrer\" target=\"_blank\">Salesforce</a> by adding it to your <a class=\"company-report-links\" data-vars-link-type=\"news_stay_updated_cta\" href=\"https://simplywall.st/features/stock-watchlist\" rel=\"noopener noreferrer\" target=\"_blank\">watchlist</a> or <a class=\"company-report-links\" data-vars-link-type=\"news_stay_updated_cta\" href=\"https://simplywall.st/features/portfolio\" rel=\"noopener noreferrer\" target=\"_blank\">portfolio</a>. Alternatively, explore our <a class=\"company-report-links\" data-vars-link-type=\"news_stay_updated_cta\" href=\"https://simplywall.st/stock/NYSE/CRM\" rel=\"noopener noreferrer\" target=\"_blank\">Community</a> to discover new perspectives on Salesforce.</p> <figure><a class=\"company-report-links\" data-vars-link-type=\"infographic\" href=\"https://www.simplywall.st/stocks/us/software/nyse-crm/salesforce/future\" rel=\"noopener noreferrer\" target=\"_blank\"><img alt=\"NYSE:CRM Earnings &amp; Revenue Growth as at Feb 2026\" class=\"sc-3204b94-0 iJdSPa\" height=\"476\" loading=\"lazy\" src=\"https://images.simplywall.st/company/1f0a3c63-9a0c-4a0a-a3c6-54ecc13e3aab/chart/earnings-and-revenue-growth?date=2026-02-26\" width=\"746\"/></a><figcaption>NYSE:CRM Earnings &amp; Revenue Growth as at Feb 2026</figcaption></figure> <p><a class=\"company-report-links\" data-vars-link-type=\"cta_news_hidden_strengths\" href=\"https://www.simplywall.st/stocks/us/software/nyse-crm/salesforce\" rel=\"noopener noreferrer\" target=\"_blank\">4 things going right for Salesforce that this headline doesn't cover.</a></p> <div class=\"relative grid grid-rows-[25px_auto] place-items-center bg-surface @container/article-body-ad [[data-brand='v2']_&amp;]:bg-surface-1\" data-cy-id=\"article-body-ad\"><div class=\"text-tiny text-softer\">Advertisement</div><div class=\"relative h-[250px] min-h-[250px] w-[300px] min-w-[300px] @[380px]/article-body-ad:h-[280px] @[380px]/article-body-ad:min-h-[280px] @[380px]/article-body-ad:w-[336px] @[380px]/article-body-ad:min-w-[336px]\"><div data-fuse=\"news_incontent_1\" id=\"news_incontent_1\"></div></div></div><h3>Quick Assessment</h3> <ul> <li><strong>‚úÖ Price vs Analyst Target</strong>: At US$191.75, Salesforce trades about 37% below the US$306.29 analyst price target range midpoint.</li> <li><strong>‚úÖ Simply Wall St Valuation</strong>: The model suggests Salesforce trades roughly 45.6% below estimated fair value, indicating room between price and intrinsic value estimates.</li> <li><strong>‚ùå Recent Momentum</strong>: The 30 day return of around 16.4% decline signals weak short term sentiment despite the AI acquisition news.</li> </ul> <p>To explore different views on the right time to buy, sell or hold Salesforce, head to Simply Wall St's\n<a class=\"company-report-links\" href=\"https://www.simplywall.st/stocks/us/software/nyse-crm/salesforce/valuation\" rel=\"noopener noreferrer\" target=\"_blank\">company report for the latest analysis of Salesforce's fair value</a>.</p> <h3>Key Considerations</h3> <ul> <li>üìä The Momentum acquisition links Salesforce's AI story directly to revenue-facing tools such as Agentforce 360 and Slack, which may matter more if you are focused on monetizable AI use cases rather than headline features.</li> <li>üìä It can be useful to watch how quickly Salesforce integrates Momentum into core workflows, any AI-related upsell metrics shared in future updates, and whether usage of AI features becomes a regular datapoint in disclosures.</li> <li>‚ö†Ô∏è A key risk is execution. If integration is slow or customer adoption of AI-driven workflows lags, the product story may not fully align with current valuation support.</li> </ul> <h3>Dig Deeper</h3> <p>For a fuller picture including more risks and potential rewards, check out the\n<a class=\"company-report-links\" href=\"https://www.simplywall.st/stocks/us/software/nyse-crm/salesforce\" rel=\"noopener noreferrer\" target=\"_blank\">complete Salesforce analysis</a>. You can also visit the\n<a class=\"company-report-links\" href=\"https://www.simplywall.st/stock/NYSE/CRM\" rel=\"noopener noreferrer\" target=\"_blank\">community page for Salesforce</a> to see how other investors believe this latest news will influence the company's narrative.</p> <p><em> This article by Simply Wall St is general in nature. <strong>We provide commentary based on historical data\n    and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice.</strong> It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your\n    financial situation. We aim to bring you long-term focused analysis driven by fundamental data.\n    Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material.\n    Simply Wall St has no position in any stocks mentioned.</em></p><div class=\"sc-80c0fb9d-0 hLZAWP\"><h3 class=\"m-0 text-balance text-mega font-medium mb-4 font-serif\"><strong>New: </strong>Manage All Your Stock Portfolios in One Place</h3><p>We've created the <strong>ultimate portfolio companion</strong> for stock investors, <strong>and it's free.</strong></p><p>‚Ä¢ Connect an unlimited number of Portfolios and see your total in one currency<br/>‚Ä¢ Be alerted to new Warning Signs or Risks via email or mobile<br/>‚Ä¢ Track the Fair Value of your stocks<br/></p><a class=\"sc-kuACkN kjLJKA !text-[--s-button-primary-color-text] !no-underline\" data-focus=\"dashed\" href=\"https://simplywall.st/features/portfolio\" target=\"_blank\">Try a Demo Portfolio for Free</a></div></div>",
            "pub_date": "2026-02-26 20:05:56",
            "link": "https://simplywall.st/stocks/us/software/nyse-crm/salesforce/news/salesforce-momentum-deal-ties-ai-workflows-to-depressed-valu",
            "source": "simplywall",
            "kind": 1,
            "language": "en"
        }
    ]
}